CN1142829A - 用于真核细胞中定点突变的化合物和方法 - Google Patents
用于真核细胞中定点突变的化合物和方法 Download PDFInfo
- Publication number
- CN1142829A CN1142829A CN94194935A CN94194935A CN1142829A CN 1142829 A CN1142829 A CN 1142829A CN 94194935 A CN94194935 A CN 94194935A CN 94194935 A CN94194935 A CN 94194935A CN 1142829 A CN1142829 A CN 1142829A
- Authority
- CN
- China
- Prior art keywords
- nucleic acid
- district
- cell
- chimeric
- hybrid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
- A01K67/027—New breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
Abstract
本发明涉及多核苷酸,它的第一链含有核糖核苷酸和脱氧核糖核苷酸两种,而第二链仅含有脱氧核糖核苷酸;其中链是Watson-Crick配对的并且通过寡核苷酸连接,如此该多核苷酸至多具有一个单一3′末端和一个单一5′末端。可将这些末端连接,这样多核苷酸就成为一个单一连续环状聚合物(single continuous circular polymer)。该多核苷酸可用于向靶基因中引入特定改变。
Description
本申请是于1993年12月9日递交的第08/164303号专利申请的后续申请,后者全文引入本文以供参考。
1.发明领域
本发明涉及分子遗传学领域。具体地说它涉及向活的、培养的真核细胞中引入特定基因改变的核酸化合物及其应用。更具体地说,它主要涉及基本上Watson-Crick配对的双链核酸,其中双链中的一条链的部分包含含2′-O或2′-OMe核糖的核苷酸,剩余部分包含脱氧核糖核苷酸。
2.发明背景
2.1.嵌合和/或杂种双链核酸
本发明领域涉及核酸。核酸是杂聚物,即不同亚单位的聚合物,亚单位是通过定向的磷酸二酯键或其衍生物连接形成聚合物。双链核酸是这样的核酸,按照尿嘧啶或胸腺嘧啶与腺嘌呤对应和胞嘧啶与鸟嘌呤对应的原则,双链中第一链的每一碱基对应于第二链的碱基。据说拥有这种对应性的逆平行双链是Watson-Crick配对的。双链核酸可有两种主要类型:核糖核酸和脱氧核糖核酸。每种核糖核苷酸都有相应的脱氧核糖核苷酸,例如,腺嘌呤和脱氧腺嘌呤,胞嘧啶和脱氧胞嘧啶,鸟嘌呤和脱氧鸟嘌呤,尿嘧啶和胸腺嘧啶。如本领域中所用的那样,在同一链中存在核糖核苷酸和脱氧核糖核苷酸的核酸被称为混合或嵌合(下文称“嵌合”)核酸。其中脱氧核糖核苷酸和核糖核苷酸相互对应的双链核酸被称为杂种双链(hybrid-duplex)。当两条链形成少于其全部碱基的双链核酸区时,所形成的分子被称为异形双链(heteroduplex)。
更经常地,双链核酸的两条链是非共价键合的,而仅通过Watson-Crick配对相连。然而,双链的两条链可通过寡核苷酸连接形成单一聚合物(single polymer)。连接寡核苷酸不是Watson-Crick配对的。其中第一链和第二链是单一聚合物的部分的异形双链被称为“发夹双链”或“柱和环”结构。本文采用前一种名称。
本文所用嵌合现象是核酸聚合物的一种特性,而杂种现象则是双链的一种特性。例如,mRNA及其模板形成杂种双链,但二者都是非嵌合的,然而例如嵌合的八核苷酸5′d(TTTT)-r(CCCC)3′和5′r(GGGG)-d(AAAA)3′相互形成Waston-Crick双链,但生成的双链是非杂种双链。下文称非杂种双链的双链核酸为“同质双链”(homo-duplex)。除非另外特别说明,同质双链仅指包含脱氧核苷酸的双链。最后,值得注意的是本领域中称Watson-Crick双链的形成为“杂交(hybridigation)”,即使其形成的是非杂种双链核酸。
对X射线衍射和二维NMR分析嵌合和/或杂种核酸结构的研究感兴趣的人们已合成了用于此研究的嵌合核酸和杂种双链核酸。参见,例如Salazar,M.等,1994,J.Mol.Biol.241:440-55和Egli,M.等,1993,Biochemistry 32:3221-37(r3d7.d10形式的双链的嵌合杂种双链);Ban,C.等,1994,J.Mol.Biol.236:275-85(d5r1d4形式的自身互补嵌合杂种双链);Chou,S.H.,1991,Biochemistry 30:5248-57(d4r4d4形式的自身互补和非自身互补的嵌合杂种双链)。这些双链核酸的互补链彼此是非共价键合的;它们仅通过Waston-Crick配对相连。
合成了嵌合核酸的第二组科学家感兴趣于核糖酶(ribozyme)的研究和用途,核糖酶即自身切开或切开其它RNA的RNA分子。Perreault,J.P.等,1990,Nature 344:565;Taylor,N.R.等,1992,Neucleic Acids Research20:4559-65;Shimaya,T.,1993,Nrucleic Acids Research 21:2605。这些研究发现嵌合核糖酶具有活性,并且对核酸酶的消化比RNA核糖酶具有更强的耐受性。嵌合核糖酶是自身互补的,即Waston-Crick配对链是共价连接的。在嵌合核糖酶的研究期间合成的化合物不同于上面提到的杂种双链分子,它们被合成用于结构的研究,因为其中的嵌合核糖酶不包括稳定的杂种双链。因而,具有DNA结合臂的嵌合核糖酶与其底物结合,并形成杂种双链。Yang,G.H.等,1990,Biochemistry 29:11156-60。还参见Sawata,S.等,1993,Neucleic Acids Research 21:5656-60;Hendry,P.等,1992,Neucleic Acids Research 20:5737-41;Shimayama,T.,1993,Neucleic Acids Research 21:2605。核糖酶催化RNA底物的切开,杂种双链因此溶解。
2.2.真核细胞中定点遗传改变
分子生物学领域的技术人员知道不仅经常需要向靶真核细胞中引入新的多核酸序列,即新的基因,而且也需要对靶细胞中确定的预先存在的基因加以改变。靶细胞可在培养物中使用或者使用它建立转基因动物。
已经建立了许多向培养的真核细胞中引入DNA的技术。这些技术包括磷酸钙沉淀法,DEAE-葡聚糖介导的胞吞作用,电穿孔,脂质体介导的融合,使用复制缺损病毒的转导作用。然而,这些技术虽然十分普遍地用于向真核细胞中引入功能性基因,但它们不能轻而易举地完成对特定存在基因的改变(突变)。引入之后,外源性DNA通过异常重组在细胞基因组中随机位点上分离,而不是通过同源重组在特定位点上分离。
迄今为止,还没有一种令人普遍满意的向高级真核细胞,即哺乳动物或鸟类细胞中引入定点或特异位点的遗传改变(诱变)的方案。虽然在真核细胞中通过引入极长(>1kb)的核酸可获得同源重组,但这些技术需要应用复杂的筛选技术,因为在高级真核细胞中异常重组率大大超过了同源重组率。Thomas,K.R.& Smithies,M.R.,1987,Cell 52:503。还参见Valancius,V.& Smithies,O.,1991,Mol.Cell.Biol.11:4389(比较真核细胞中线性化和超螺旋质粒的同源重组)。
一种完成优势定点诱变的方法是向细胞中直接引入单链寡脱氧核苷酸。这一技术被成功地用于酵母中,同源重组在啤酒酵母(Saccharomycescerevisiae)中的活性显著高于真核细胞。Moreschell,R.P.等,1988,Proc.Natl.Acad.Sci.85:524-28;Yamamoto,T.等,1992,Yeast 8:935-48。并且,至今也没有用单链寡核苷酸成功地转化哺乳动物或鸟类细胞的报道。
研究表明改变的嘌呤和嘧啶上碱基区,即〔d(TG)30·d(AC)30〕显示显示了令人喜悦的重组率,由此可推知哺乳动物中靶DNA结构和同源重组率之间的关系。对培养的哺乳动物细胞的非复制质粒的研究证实了这些效果。Wahls,W.P.等,1990,Mol.Cell.Biol.10:785-93。这些实验没有进而表明外源性核酸和细胞基因组之间的重组。
曾尝试使用RecA,一种促进细菌(大肠杆菌)中同源重组的蛋白质来促进真核细胞中的同源重组。但是,这些尝试显然未获得成功。例如,W.Bertling的美国专利4950599公开了在真核细胞中使用RecA导致极低的定向位点突变率,并且同源重组率也未增高。D.Zarling和E.Sane的专利申请WO93/22443及D.C.Gruenert和Z.Kunzelmann的申请94/04032都旨在校正培养的涉及囊纤维变性的细胞系中的基因缺损。这些出版物公开了证实原理的原始实验数据而非涉及操作方法实施例的数据。为将多核苷酸/RecA复合物引入到核中,Zarling和Gruenert使用膜是通透性的细胞,尽管这类细胞不能进一步生长。另外,即使这些出版物宣称在完整细胞中发生了RecA促进同源重组,它们也未给出对其频率的定量评价。因此,还没有证据可令人信服地表明在任何活的真核细胞中,使用原核RecA导致的同源重组率明显高于自发性同源重组率。
3.发明概述
本发明涉及单一共价连接的双链寡核苷酸,它与所研究的基因同源,且具有脱氧核糖核苷酸和核糖核苷酸。为了产生遗传改变,在同源区内,有一对或多对非对应(下文称“异源”或“突变基因”)碱基对。通常,细胞原有的同源重组过程导致突变基因核苷酸插入靶基因组位置。可使用本发明的双链寡核苷酸(下文称“嵌合载体”)向基因中引入异源碱基对,特定地改变所研究的基因。异源碱基对可能是不同于所研究的基因的碱基对,或者可能是所研究基因中存在的碱基对之外那些碱基对(插入),或者异源碱基对还可能是不存在于所研究基因中的碱基对(缺失)。本发明部分地是基于下述发现,即载体中包含杂种双链核酸的约15-50个碱基对区大大提高所研究基因的改变率。当异源碱基对区是1-50个碱基对时,异源碱基对可以同质或杂种双链存在于本发明的载体中。当异源碱基对长度大于50个碱基对时,它优选以同质双链存在。
可采用任何已知的向真核细胞中引入核酸的方法向靶细胞中引入载体。虽然就理论而言没有限定,但据信嵌合载体是通过靶细胞的重组/修复机制来参与的,并且经基因转化或同源重组指导靶基因改变。
4.附图的简要说明
图1显示图表表示的两种嵌合载体。特定标记如下:1,第一链;2,第二链;3,异源区;4,同质区;5,连接物;6,连接位点。
图1A是R-D-R形式的连接的嵌合载体。
图1B是R-D-R形式的具有单一3′和5′末端的发夹式嵌合载体。
5.发明详述
5.1.本发明嵌合载体的描述
本发明包括含有含脱氧核糖和核糖的碱基双链核酸。因此它们包括DNA和RNA区,故而被称为“嵌合载体”。嵌合载体的核糖核苷酸的2′-O可以是甲基化的。任何磷酸二酯都可被硫代磷酸二酯或甲基磷酸二酯替代。
本发明的嵌合载体是单一核酸聚合物。因此本发明的嵌合载体须至少包括1个碱基至更通常的3或4个碱基,这些碱基不是Watson-Crick配对的。这些未配对碱基区连接两条Waston-Crick配对的碱基链。与其它合成的具有未配对核苷酸的嵌合核苷酸相反嵌合载体没有酶活性,即它们不催化化学反应或者在没有生物能源,如ATP存在下它们自身进行化学反应。
优选实施方案中的连接区碱基是脱氧核糖核苷酸。可构建具有两个连接区的嵌合载体,以使聚合物的3′和5′末端与相邻的互补链核苷酸呈Waston-Crick配对。它们易于连接使嵌合载体形成单一连续环状核酸聚合物。
基本上,嵌合载体的所有其余碱基都是Waston-crick配对的。本文所描述的碱基是Waston-Crick配对的或它们形成双链核酸应被理解为在适当的温度和盐的条件下,它们可形成碱基对或双链核酸。应该知道在某些少盐和/或升高的温度条件下,Waston-crick碱基对会失去热力学稳定性而使得双链核酸熔解掉或变性。还应知道一或两对碱基对失配并不影响本发明的可操作性。
本发明的嵌合载体旨在将改变(突变)特定地引入靶基因。通过选择具有与靶位点序列相同(同源)序列的嵌合载体部分(下文称之为同源区)确定遗传改变位点。嵌合载体序列和靶基因之间的不同区被称为异源区。应注意到嵌合载体与靶基因虽是异源的,但在该载体区中并不是异形双链。根据本发明的优选实施方案,每个嵌合载体有两个同源区,它们位于插入的异源区侧翼,所有这三个区都以单一连续双链核酸形式存在。再有,依据本发明,每个同源区包括杂种双链核酸部分。每个杂种双链至少是4对碱基对,优选为8对碱基对,更优选为约20-30对碱基对。嵌合载体的作用并不受到杂种双链区内同质双链的二核苷酸碱基对的影响,置入嵌合载体使3′和5′末端彼此连接。两个同源区的长度至少为20对碱基对,优选在40-60对碱基对之间。
依据本发明,可将同质双链核酸区排列在载体的杂种双链/同源区之间。被插入的同质双链区可包括异源区。当异源区少于约50对碱基对,优选地少于约20对碱基对时,可存在或不存在被插入的同质双链区。当异源区超过约20对碱基对时,包含异源区的被插入同质双链是优选的。
5.2.本发明的嵌合载体的构建
可使用任意方法合成本发明的嵌合载体。使用经改进的用于DNA固相合成的技术可最简便地合成嵌合载体。参见Caruthers,M.H.,1985,Science 230:281-85;Itakura,K.等,1984,Ann.Rev.Biochem.53:523-56。可合成RNA和嵌合核酸的改进方法公开于Scaringe,S.A.等,1990,NucleicAcids Research 18:5433-41;Usman,N.等,1992,Nucleic Acids Research20:6695-99;和Swiderski,P.M.等,1994,Anal.Biochem.216:83-88,上述文献均全文引入本文以供参考。有关嵌合核酸合成的新近进展综述于Usman,N.& Cedergren,R.,1992,Trends Bioch.Sci.17:334-9。
插入两个杂种双链区之间的包含同质双链区的嵌合载体可使用半合成技术来建立。构建两种合成的具发夹构象的嵌合多聚核酸。使用与两种不同限制酶的消化产物的重叠部分互补的重叠交叉末端,构建两种嵌合核酸的游离3′和5′末端。得到与限制酶消化末端互补的同质双链区。可采用本领域技术人员熟知的技术来完成限制酶位点与克隆DNA片段末端的加成,所述技术例如,但不限于使用伸展引物的PCR扩增和包含限制位点的连接体的平整末端连接。可使用常规的酶促技术连接两种嵌合核苷酸和同质双链区。通过在Tris Borate EDTA缓冲液中的6%聚丙烯酰胺电泳从不完全反应的底物中分离两个末端连接的嵌合寡核苷酸。该线性加帽的分子是压缩的并且在这一条件下的电泳更缓慢。
仅含有天然产生的核苷酸的嵌合载体也可用于本发明。据发现包含约20个核糖核苷酸的杂种双链区的嵌合载体在体外是RNAse H抗性的。可通过用2′-O甲基化核糖核苷酸替代核糖核苷酸获得对酶促降解的抗性。另外或者可选择性地,核酸的磷酸二酯键可被硫代磷酸二酯键替代。Shimayama,T.等,1993,Nucleic Acids Research 21:2605.也可以使用含阿拉伯糖的核苷酸。本文所用术语核酸意指包括带有这些修饰的核酸。
5.3.本发明的嵌合载体的应用
本发明的嵌合载体可用于靶细胞基因组的特定位置上的突变。采用其核酸序列定义靶位的特定位置,下文中称此核酸序列为靶序。依据本发明构建嵌合载体,其中除存在某些杂种双链区外,同源区与靶序列一致。异源区编码被引入的变化。变化可是序列的一个或多个碱基变化或者是一个或多个碱基的加成。当靶序列的变化是少于约20个碱基的加成时,可采用一或二个杂种双链区实现本发明。当靶序列的变化是多于约50个碱基的加成时,则优选采用被包括在同质双链区内的异源区。
本发明的实现要求向靶细胞核中引入嵌合载体。任何导致这种引入的方法均可使用。这类方法包括电穿孔法,DEAE葡聚糖法,磷酸钙沉淀法,脂质体介导的融合法(LIPOFECTIN)和直接注射法。电穿孔法是特别适合的。
在本发明的一个实施方案中嵌合载体用于建立转基因动物。按照文献描述方法,采用直接注射法向卵细胞的原核中引入嵌合载体,所述文献是Brinster R.L.等,1989,PROC.NATL.ACAD.SCI.86:7087;还有T.E.Wagner和P.C.Hoppe的美国专利4,873,191,二者都全文引入本文以供参考。另外,可向胚胎干细胞中引入嵌合载体,可用正常胚泡细胞聚集胚胎干细胞从而产生嵌合动物,以嵌合动物的后代可重新获得转基因动物,该方法参见Capccchi,M.R.,1989,Science 244:1288,该文献全文引入本文以供参考。
采用电穿孔法,每10,000个被处理细胞就有一个细胞在靶序列上发生特异性突变(下文称“转化”)。因此,本发明的实践包括从大量未突变细胞中选择转化细胞的方法的使用。在另一个实施方案中,转化细胞的优点增多。这些增多的优点的非限制性实例包括抗药性,生长调节的改变和利用代谢物能力的改变。在另一个实施例中,选择方法是负选择法,使用该方法在所选择条件下使得被转化细胞不能生长,并且通过使其暴露在选择性破坏增殖细胞的条件下而除去未被转化的细胞。
另外,被转化的细胞可具有改变的细胞表面抗原表型,它可通过免疫荧光进行检测,采用荧光激活细胞分离器进行选择。
当向细胞中引入嵌合载体的方法是直接注射法时,例如当采用原核注射法建立转基因动物时,每10,000个细胞的转化率可高于1个细胞。因此,大大降低了选择的需要。
采用电穿孔法转化的嵌合载体的典型用量是每百万个培养细胞在10-1000ng之间。
6.实施例
6.1.实施例1:对黑粉菌属真菌的体内活性
野生型黑粉菌具有功能性的尿嘧啶(ura)-3基因,其产物是尿嘧啶生物合成途径中的一部分。当野生型黑粉菌生长于5′-fluororotic acid(5FOA)培养基中时,细胞由于该酸加入到上述途径中而死亡。假如尿嘧啶-3发生突变,则不会产生尿嘧啶-3mRNA,细胞就得以在5FOA培养基中存活。
内源性尿嘧啶-3基因序列是本领域中已知的。在一组实验中,该序列的碱基358由腺嘌呤变为胸腺嘧啶,这一突变导致功能障碍蛋白的产生。
嵌合载体的合成如下:
碱基358突变的载体:(358 RNA载体)
5′TGCCGATCGGCAACTTTTGUUGCCGAUCGGCAAATTT 3′(SEQ ID:1)
该358载体采用发夹构象。划线碱基表示核糖核酸残基。黑体字母表示突变基因(异型区)。斜体"T"表示未配对碱基。
建立具有相同序列但不包含核糖核酸的载体作为对照。在该载体中胸腺嘧啶被尿嘧啶替代。
对照载体在碱基358进行突变:(DNA 358载体)
5′TGCCGATCGGCAACTTTTGTTGCCGATCGGCAAATTT 3′
(SEQ ID:2)也采用发夹构象。再者,黑体残基是突变基因。
进行体内转化实验,按照本领域所熟知的方法,将U.maydis细胞制成回收率为50ul转化缓冲液中106个细胞的原生质体,并使用不同量的嵌合载体进行转染或者将同源(仅DNA)载体与原生质体在37℃混合。然后,将细胞铺于所选择的培养基上,计数存活菌落(转化细胞)的数目。结果以下面的表格形式表示:
转染数量(ug) | 载体-358类型 | 存活菌落数 |
0.1 | DNA | 0 |
0.1 | 嵌合的 | 13 |
0.25 | DNA | 1 |
0.25 | 嵌合的 | 49 |
0.75 | DNA | 12 |
0.75 | 嵌合的 | 131 |
1.0 | DNA | 19 |
1.0 | 嵌合的 | 573 |
这些数据表明使用RNA 358载体的细胞转染与使用相应DNA载体的转染相比,极大地提高了细胞的存活率。
6.2.实施例2:NIH 3T3细胞的转化
NIH 3T3细胞是具有良性(可控制的)生长特性的人细胞。恶性(无控制的)生长特性是由致癌基因H→ras中的单位点突变给予的,所谓突变是由Thr替代Gly12。这样,G→T12导致生长特性的易于选择的变化。Taparowsky,E.等,1982,Nature 300:762;Sukumar S.等,1983,Nature306:658。
建立下述序列以指导发生G→T12突变的嵌合载体:5′-CACACCGACGGCGCCCACCACTTTGTGGTGGGCGCCGTCGGTGTGGGTTTGCC-3′(SEQ ID:3)
该序列以常规单字母代码表示,其它特点是未划线的表示RNA,未配对碱基是斜体,突变体碱基是黑体。需要注意的是,环化之后通过两个三胸腺嘧啶序列将嵌合载体分为两条基本上互补的链,并且所有含核糖的核苷酸仅存在于两条链中的一条。
使用2′-OMe核糖碱基合成两种形式的嵌合载体,它们分别具有一个("R")和两个("R-D-R")的翼侧有四个脱氧核糖残基的杂种双链区。R-D-R形式如上SEQ ID:3所示,R形式除碱基6-9是脱氧核苷酸外是相同的。值得注意的是,5′和3′末端是脱氧核苷酸。采用如在重组DNA中常用的相同DNA连接酶法,在合成之后环化嵌合载体。连接之后,通过两次重复的制备性D600凝胶(AT Biochem,Malvern,PA)电泳从底物中分离环化嵌合载体。
对照载体是:1)没有杂种双链的相同序列(“同质双链”
所示数据);2)具有5′-GCCCACACCGACGGCGCCACCAC-3′(SEQ ID 4)序列的未配对DNA(“sDNA”所示数据);3)没有异源区的嵌合载体,因而是没有突变基因的核苷酸(未显示数据)。
采用电穿孔法通过转化NIH 3T3细胞(1×106个细胞)进行实验。电穿孔法之后,将细胞以4×103个接种密度铺于培养基中并使其生长14天。用结晶紫染色灶形成细胞使转化细胞可见。使用编码T12形式的H ras的质粒pT24作为阳性对照。该对照用于测定转染的NIH 3T3细胞中的异常重组水平。该实验重复5次,下表表示其概括性结果。除下面所示结果外,使用没有突变基因密码子的嵌合载体的对照实验未显示出NIH 3T3细胞转化灶。
载体类型 | 转染量(每106个细胞) | 转化细胞每106个细胞(14天) |
pT24(阳性对照) | 10ug | 57 |
sDNA | 1ug | 2 |
sDNA | 10ug | 13 |
同质双链 | 1ug | 0 |
同质双链 | 10ug | 2 |
嵌合的 | 50ng | R-D-R R19 12 |
嵌合的 | 200ng | 55 43 |
嵌合的 | 1ug | 139 103 |
这些结果表明嵌合载体通过同源重组引入特定突变以转化哺乳动物细胞。该实验中的转化率大大高于通过异常重组的转化率,这是由使用包含完全突变的H-ras基因的pT24阳性对照载体进行转染观察到的。因此,在哺乳动物细胞中使用嵌合载体的同源重组率远远高于异常重组率。
序列表
(1)普通信息:
(i)申请者:Kmiec,Eric
(ii)发明题目:用于真核细胞中定点突变的化合物和方法
(iii)序列数:4
(iv)通讯地址:
(A)收信人:Pennie & Edmonds
(B)街道:1155 Avenue of the Americas
(C)城市:New York
(D)国家:NY
(F)邮政编码:10036-2731
(V)可读计算机源:
(A)媒介类型:软盘
(B)计算机:IBM PC兼容机
(C)操作系统:PC-DOS/MS-DOS
(D)软件:PatentIn Release #1.0,Version #1.25
(vi)当前申请资料:
(A)申请号:US
(B)递交日:
(C)分类:
(viii)律师/代理人信息:
(A)姓名:Friebel,Thomas E.
(B)注册号:29,258
(C)文献/摘要号:7991-009
(ix)通讯信息:
(A)电话:(212)790-9090
(B)传真:(212)869-8864/009(2)第一序列(SEQ ID:1)信息:(i)序列特征:(A)长度:37对碱基对(B)类型:核酸(C)链合方式:自身互补(D)拓扑结构:线性(ii)分子类型:DNA/RNA(ix)特点:(A)名称/检索表:-(B)位点:19..32(D)其它信息:/标记=a/注="RNA"(xi)序列描述:第一序列描述:TGCCGATCGG CAACTTTTGU UGCCGAUCGG CAAATTT 37(2)第二序列(SEQ ID:2)信息:(i)序列特征:(A)长度:37对碱基对(B)类型:核酸(C)链合方式:自身互补(D)拓扑结构:线性(ii)分子类型:DNA(xi)序列描述:第二序列描述:TGCCGATCGG CAACTTTTGT TGCCGATCGG CAAATTT 37(2)第三序列(SEQ ID:3)信息:(i)序列特征:(A)长度:53对碱基对(B)类型:核酸(C)链合方式:自身互补(D)拓扑结构:线性(ii)分子类型:DNA/RNA(ix)特点:(A)名称/检索表:-(B)位点:2..5(D)其它信息:/标记=b/注="RNA"(ix)特点:(A)名称/检索表:(B)位点:10..21(D)其它信息:/标记=d/注=“RNA”(ix)特点:(A)名称/检索表:(B)位点:51..52(D)其它信息:/标记=f/注=“RNA”(xi)序列描述:第三序列描述:CACACCGACG GCGCCCACCA CTTTGTGGTG GGCGCCGTCG GTGTGGGTTT GCC 53(2)第四序列(SEQ ID:4)信息:(i)序列特征:(A)长度:23对碱基对(B)类型:核酸(C)链合方式:自身互补(D)拓扑结构:线性(ii)分子类型:DNA(xi)序列描述:第四序列描述:GCCCACACCG ACGGCCCCAC CAC 23
Claims (17)
1.一种至多具有一个3′末端和一个5′末端的嵌合核酸,该核酸还包含:
a.邻接排列的未配对碱基区,这样未配对区将核酸分为第一链和第二链;
b.长度至少为15对碱基对的Watson-Crick配对的核酸区,其中,第一链的碱基对应于第二链的碱基,以及其中;
c.第一链包含至少三个邻接的由2′-O或2′-OMe核糖组成的核苷酸区,在杂种双链(hybrid-duplex)中它们是Watson-Crick配对的。
2.权利要求1的核酸,其中第二链不包含由2′-O或2′-OMe核糖组成的核苷酸。
3.权利要求2的核酸,其中杂种双链至少包含9个邻接的由2′-O核糖组成的核苷酸,其翼侧为由2′-脱氧核糖组成的核苷酸。
4.权利要求2的核酸,其中第一链包含两个邻接的由2′-O或2′-OMe核糖组成的核苷酸区,它们形成两个杂种双链区,每个杂种双链区的长度至少为4对碱基对,并且同质双链(homo-duplex)插入区排列于两个杂种双链区之间,该插入区为至少1对碱基对。
5.权利要求2的核酸,其中第一链包含两个由2′-O或2′-OMe核糖组成的核苷酸区,它们形成两个杂种双链区,每个杂种双链区的长度至少为8对碱基对,并且同质双链插入区排列于两个杂种双链区之间,该插入区为至少4对碱基对。
6.权利要求5的核酸,其中同质双链插入区由4-50对2′-脱氧核糖碱基对组成。
7.权利要求5的核酸,其中同质双链插入区由30-1,000对2′-脱氧核糖碱基对组成。
8.权利要求2的核酸,其中5′和3′末端是连接的。
9.权利要求5的核酸,其中5′和3′末端是连接的。
10.权利要求6的核酸,其中5′和3′末端是连接的。
11.权利要求7的核酸,其中5′和3′末端是连接的。
12.一种将预定改变引入有核细胞基因组的靶序列中的方法,它包括下述步骤:
a.提供一种嵌合载体,它具有两个靶序列同源区,和一个排列在两个同源区之间的编码这种改变的异源区;
b.使嵌合载体保持在细胞核中,以使嵌合载体与靶序列发生遗传学重组。
13.权利要求12的方法,其中核是卵的原核并且采用直接注射法引入。
14.权利要求12的方法,其中核是胚胎干细胞核并且采用直接注射法引入。
15.一种获得改变特征的细胞群的方法,它包括下述步骤:
a.提供一种嵌合载体,它具有两个靶序列同源区,和一个排列在两个同源区之间的编码这种改变的异源区;
b.使嵌合载体保持在细胞核中,由此嵌合载体与靶序列发生重组,细胞被转化;及
c.选择转化细胞。
16.权利要求15的方法,其中细胞是哺乳动物细胞。
17.权利要求15的方法,其中细胞是酵母菌或真菌。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16430393A | 1993-12-09 | 1993-12-09 | |
US08/164,303 | 1993-12-09 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98118786A Division CN1117866C (zh) | 1993-12-09 | 1998-08-22 | 将预定改变引入有核细胞基因组的靶序列中的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1142829A true CN1142829A (zh) | 1997-02-12 |
CN1048254C CN1048254C (zh) | 2000-01-12 |
Family
ID=22593886
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN94194935A Expired - Fee Related CN1048254C (zh) | 1993-12-09 | 1994-12-09 | 用于将预定的改变引入靶基因中的化合物 |
CN98118786A Expired - Fee Related CN1117866C (zh) | 1993-12-09 | 1998-08-22 | 将预定改变引入有核细胞基因组的靶序列中的方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98118786A Expired - Fee Related CN1117866C (zh) | 1993-12-09 | 1998-08-22 | 将预定改变引入有核细胞基因组的靶序列中的方法 |
Country Status (15)
Country | Link |
---|---|
US (3) | US5565350A (zh) |
EP (1) | EP0733059B1 (zh) |
JP (1) | JP3585238B2 (zh) |
KR (1) | KR100386337B1 (zh) |
CN (2) | CN1048254C (zh) |
AT (1) | ATE196311T1 (zh) |
AU (1) | AU691550B2 (zh) |
CA (1) | CA2178729A1 (zh) |
DE (2) | DE69425903T2 (zh) |
DK (1) | DK0733059T3 (zh) |
ES (1) | ES2149962T3 (zh) |
GR (1) | GR3034988T3 (zh) |
NZ (1) | NZ278490A (zh) |
PT (1) | PT733059E (zh) |
WO (1) | WO1995015972A1 (zh) |
Families Citing this family (786)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU739601B2 (en) * | 1991-07-03 | 2001-10-18 | Meditech Research Limited | Use of hyaluronan in gene therapy |
US6335434B1 (en) | 1998-06-16 | 2002-01-01 | Isis Pharmaceuticals, Inc., | Nucleosidic and non-nucleosidic folate conjugates |
US8153602B1 (en) | 1991-11-19 | 2012-04-10 | Isis Pharmaceuticals, Inc. | Composition and methods for the pulmonary delivery of nucleic acids |
US20020108136A1 (en) * | 1997-03-21 | 2002-08-08 | Sri | Transgenic animals produced by homologous sequence targeting |
US5523389A (en) * | 1992-09-29 | 1996-06-04 | Isis Pharmaceuticals, Inc. | Inhibitors of human immunodeficiency virus |
ATE247128T1 (de) | 1993-09-03 | 2003-08-15 | Isis Pharmaceuticals Inc | Aminoderivatisierte nukleoside und oligonukleoside |
US6420549B1 (en) | 1995-06-06 | 2002-07-16 | Isis Pharmaceuticals, Inc. | Oligonucleotide analogs having modified dimers |
US5760012A (en) * | 1996-05-01 | 1998-06-02 | Thomas Jefferson University | Methods and compounds for curing diseases caused by mutations |
US5731181A (en) * | 1996-06-17 | 1998-03-24 | Thomas Jefferson University | Chimeric mutational vectors having non-natural nucleotides |
US20030044941A1 (en) | 1996-06-06 | 2003-03-06 | Crooke Stanley T. | Human RNase III and compositions and uses thereof |
US9096636B2 (en) * | 1996-06-06 | 2015-08-04 | Isis Pharmaceuticals, Inc. | Chimeric oligomeric compounds and their use in gene modulation |
US7812149B2 (en) | 1996-06-06 | 2010-10-12 | Isis Pharmaceuticals, Inc. | 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations |
US5898031A (en) | 1996-06-06 | 1999-04-27 | Isis Pharmaceuticals, Inc. | Oligoribonucleotides for cleaving RNA |
ATE264864T1 (de) * | 1997-03-03 | 2004-05-15 | Applera Corp | Verbesserte chimäre oligonukleotidvektoren |
US5948653A (en) * | 1997-03-21 | 1999-09-07 | Pati; Sushma | Sequence alterations using homologous recombination |
US6524613B1 (en) | 1997-04-30 | 2003-02-25 | Regents Of The University Of Minnesota | Hepatocellular chimeraplasty |
GB9711015D0 (en) * | 1997-05-28 | 1997-07-23 | Zeneca Ltd | Improvements in or relating to organic compounds |
WO1999001579A1 (en) | 1997-07-01 | 1999-01-14 | Isis Pharmaceuticals, Inc. | Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
WO1999007865A1 (en) * | 1997-08-05 | 1999-02-18 | Kimeragen, Inc. | The use of mixed duplex oligonucleotides to effect localized genetic changes in plants |
AU1526199A (en) | 1997-11-18 | 1999-06-07 | Pioneer Hi-Bred International, Inc. | Targeted manipulation of herbicide-resistance genes in plants |
US7102055B1 (en) | 1997-11-18 | 2006-09-05 | Pioneer Hi-Bred International, Inc. | Compositions and methods for the targeted insertion of a nucleotide sequence of interest into the genome of a plant |
PT1034262E (pt) * | 1997-11-18 | 2005-10-31 | Pioneer Hi Bred Int | Composicoes e metodos para a modificacao genetica de plantas |
EP0945507A1 (de) * | 1998-03-27 | 1999-09-29 | Boehringer Mannheim Gmbh | Tumorspezifische Expressionskontrollregion und deren Verwendung |
US20040186071A1 (en) | 1998-04-13 | 2004-09-23 | Bennett C. Frank | Antisense modulation of CD40 expression |
US6010907A (en) | 1998-05-12 | 2000-01-04 | Kimeragen, Inc. | Eukaryotic use of non-chimeric mutational vectors |
US6004804A (en) | 1998-05-12 | 1999-12-21 | Kimeragen, Inc. | Non-chimeric mutational vectors |
EP1080103A4 (en) * | 1998-05-21 | 2003-07-02 | Isis Pharmaceuticals Inc | COMPOSITIONS AND METHODS FOR NON-PARENTERAL ADMINISTRATION OF OLIGONUCLEOTIDES |
US6841539B1 (en) | 1998-05-21 | 2005-01-11 | Isis Pharmaceuticals, Inc. | Compositions and methods for topical delivery of oligonucleotides |
US6693185B2 (en) | 1998-07-17 | 2004-02-17 | Bayer Bioscience N.V. | Methods and means to modulate programmed cell death in eukaryotic cells |
DE19836098A1 (de) | 1998-07-31 | 2000-02-03 | Hoechst Schering Agrevo Gmbh | Pflanzen, die eine modifizierte Stärke synthetisieren, Verfahren zur Herstellung der Pflanzen, ihre Verwendung sowie die modifizierte Stärke |
US6077709A (en) | 1998-09-29 | 2000-06-20 | Isis Pharmaceuticals Inc. | Antisense modulation of Survivin expression |
JP2003523166A (ja) | 1998-09-29 | 2003-08-05 | ガミダ セル リミテッド | 幹細胞および前駆細胞の増殖と分化を制御する方法 |
CN100408687C (zh) | 1998-11-09 | 2008-08-06 | 拜尔生物科学有限公司 | 来自稻米的核酸分子及其用于生产改性淀粉的用途 |
US6438561B1 (en) * | 1998-11-19 | 2002-08-20 | Navigation Technologies Corp. | Method and system for using real-time traffic broadcasts with navigation systems |
WO2000042559A1 (en) * | 1999-01-18 | 2000-07-20 | Maxygen, Inc. | Methods of populating data structures for use in evolutionary simulations |
US20030054390A1 (en) * | 1999-01-19 | 2003-03-20 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
US6917882B2 (en) | 1999-01-19 | 2005-07-12 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
US6376246B1 (en) | 1999-02-05 | 2002-04-23 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
US6368861B1 (en) | 1999-01-19 | 2002-04-09 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
EP1108783A3 (en) * | 1999-01-19 | 2001-09-05 | Maxygen, Inc. | Oligonucleotide-mediated nucleic acid recombination |
US20070065838A1 (en) | 1999-01-19 | 2007-03-22 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
US6961664B2 (en) | 1999-01-19 | 2005-11-01 | Maxygen | Methods of populating data structures for use in evolutionary simulations |
US7024312B1 (en) * | 1999-01-19 | 2006-04-04 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
US6127124A (en) * | 1999-01-20 | 2000-10-03 | Isis Pharmaceuticals, Inc. | Fluorescence based nuclease assay |
WO2000061184A2 (en) * | 1999-04-08 | 2000-10-19 | Glenn Gregory M | Dry formulation for transcutaneous immunization |
US7098192B2 (en) | 1999-04-08 | 2006-08-29 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of STAT3 expression |
WO2000068389A2 (en) | 1999-05-07 | 2000-11-16 | E. I. Du Pont De Nemours And Company | Auxin transport proteins |
US6656730B1 (en) | 1999-06-15 | 2003-12-02 | Isis Pharmaceuticals, Inc. | Oligonucleotides conjugated to protein-binding drugs |
US6271360B1 (en) | 1999-08-27 | 2001-08-07 | Valigen (Us), Inc. | Single-stranded oligodeoxynucleotide mutational vectors |
AR025996A1 (es) * | 1999-10-07 | 2002-12-26 | Valigen Us Inc | Plantas no transgenicas resistentes a los herbicidas. |
AU7875400A (en) | 1999-10-07 | 2001-05-10 | Valigen, Inc. | Compositions and methods for plant genetic modification |
US7430477B2 (en) | 1999-10-12 | 2008-09-30 | Maxygen, Inc. | Methods of populating data structures for use in evolutionary simulations |
US7332275B2 (en) | 1999-10-13 | 2008-02-19 | Sequenom, Inc. | Methods for detecting methylated nucleotides |
WO2001035735A1 (en) * | 1999-11-19 | 2001-05-25 | Hematech, Llc | Production of ungulates, preferably bovines that produce human immunoglobulins |
US7414170B2 (en) * | 1999-11-19 | 2008-08-19 | Kirin Beer Kabushiki Kaisha | Transgenic bovines capable of human antibody production |
US7074983B2 (en) * | 1999-11-19 | 2006-07-11 | Kirin Beer Kabushiki Kaisha | Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin |
US7820878B2 (en) * | 1999-11-19 | 2010-10-26 | Kyowa Hakko Kirin Co., Ltd. | Production of ungulates, preferably bovines that produce human immunoglobulins |
US6261840B1 (en) | 2000-01-18 | 2001-07-17 | Isis Pharmaceuticals, Inc. | Antisense modulation of PTP1B expression |
US20020055479A1 (en) | 2000-01-18 | 2002-05-09 | Cowsert Lex M. | Antisense modulation of PTP1B expression |
US20060134629A1 (en) * | 2000-03-20 | 2006-06-22 | Link Charles J | Methods and compositions for elucidating protein expression profiles in cells |
US6897020B2 (en) * | 2000-03-20 | 2005-05-24 | Newlink Genetics Inc. | Methods and compositions for elucidating relative protein expression levels in cells |
US6936467B2 (en) * | 2000-03-27 | 2005-08-30 | University Of Delaware | Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
MXPA02009627A (es) * | 2000-03-27 | 2004-05-14 | Univ Delaware | Modificaciones genomicas cromosomicas selectivas con oligonucleotidos modificados de un solo filamento.. |
CA2409172A1 (en) * | 2000-05-17 | 2001-11-22 | University Of Delaware | Plant gene targeting using oligonucleotides |
US6686188B2 (en) * | 2000-05-26 | 2004-02-03 | Amersham Plc | Polynucleotide encoding a human myosin-like polypeptide expressed predominantly in heart and muscle |
US6656700B2 (en) * | 2000-05-26 | 2003-12-02 | Amersham Plc | Isoforms of human pregnancy-associated protein-E |
WO2001094610A2 (en) * | 2000-06-05 | 2001-12-13 | Thomas Jefferson University | Binary hybrid mutational vectors |
US7468475B2 (en) | 2000-06-16 | 2008-12-23 | Schmuelling Thomas | Method for modifying plant morphology, biochemistry and physiology |
US6958214B2 (en) | 2000-07-10 | 2005-10-25 | Sequenom, Inc. | Polymorphic kinase anchor proteins and nucleic acids encoding the same |
NZ524366A (en) * | 2000-07-27 | 2005-12-23 | Univ Delaware | Methods for enhancing targeted gene alteration using oligonucleotides |
US6875907B2 (en) | 2000-09-13 | 2005-04-05 | Pioneer Hi-Bred International, Inc. | Antimicrobial peptides and methods of use |
WO2002026967A2 (en) * | 2000-09-25 | 2002-04-04 | Thomas Jefferson University | Targeted gene correction by single-stranded oligodeoxynucleotides |
US20020123474A1 (en) * | 2000-10-04 | 2002-09-05 | Shannon Mark E. | Human GTP-Rho binding protein2 |
US7560622B2 (en) | 2000-10-06 | 2009-07-14 | Pioneer Hi-Bred International, Inc. | Methods and compositions relating to the generation of partially transgenic organisms |
US7491534B2 (en) | 2000-12-22 | 2009-02-17 | Kirin Holdings Kabushiki Kaisha | Methods for altering cell fate to generate T-cells specific for an antigen of interest |
US20020142397A1 (en) * | 2000-12-22 | 2002-10-03 | Philippe Collas | Methods for altering cell fate |
NZ525607A (en) * | 2000-12-22 | 2005-05-27 | Aurox Llc | Methods for cloning mammals using reprogrammed donor chromatin or donor cells |
WO2002059337A1 (en) * | 2001-01-26 | 2002-08-01 | Georgetown University School Of Medicine | Anti-apoptopic gene scc-s2 and diagnostic and therapeutic uses thereof |
EP1414840A4 (en) * | 2001-03-27 | 2005-04-13 | Univ Delaware | GENOMIC APPLICATIONS FOR MODIFIED OLIGONUCLEOTIDES |
WO2002081642A2 (en) | 2001-04-06 | 2002-10-17 | Georgetown University | Gene brcc-3 and diagnostic and therapeutic uses thereof |
AU2002303262A1 (en) * | 2001-04-06 | 2002-10-21 | Georgetown University | Gene shinc-1 and diagnostic and therapeutic uses thereof |
WO2002081639A2 (en) * | 2001-04-06 | 2002-10-17 | Georgetown University | Gene brcc2 and diagnostic and therapeutic uses thereof |
AU2002305151A1 (en) * | 2001-04-06 | 2002-10-21 | Georgetown University | Gene scc-112 and diagnostic and therapeutic uses thereof |
US20040063922A1 (en) * | 2001-04-17 | 2004-04-01 | Conrad Charles A. | Methods and compositions for catalytic DNA exchange in a sequence specific manner |
US20030045830A1 (en) * | 2001-04-17 | 2003-03-06 | De Bizemont Therese | Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis |
US7053195B1 (en) | 2001-06-12 | 2006-05-30 | Syngenta Participatious Ag | Locked nucleic acid containing heteropolymers and related methods |
US7803915B2 (en) | 2001-06-20 | 2010-09-28 | Genentech, Inc. | Antibody compositions for the diagnosis and treatment of tumor |
MXPA03011985A (es) | 2001-06-20 | 2004-03-26 | Genentech Inc | Composiciones y metodos para el diagnostico y tratamiento de tumores. |
CA2451643C (en) | 2001-06-21 | 2012-11-13 | Isis Pharmaceuticals, Inc. | Antisense modulation of superoxide dismutase 1, soluble expression |
EP1925672A1 (en) | 2001-06-22 | 2008-05-28 | Syngeta Participations AG | Abiotic stress responsive polynucleotides and polypeptides |
US6964950B2 (en) | 2001-07-25 | 2005-11-15 | Isis Pharmaceuticals, Inc. | Antisense modulation of C-reactive protein expression |
US7425545B2 (en) | 2001-07-25 | 2008-09-16 | Isis Pharmaceuticals, Inc. | Modulation of C-reactive protein expression |
US20030096772A1 (en) | 2001-07-30 | 2003-05-22 | Crooke Rosanne M. | Antisense modulation of acyl CoA cholesterol acyltransferase-2 expression |
US7407943B2 (en) | 2001-08-01 | 2008-08-05 | Isis Pharmaceuticals, Inc. | Antisense modulation of apolipoprotein B expression |
US7227014B2 (en) | 2001-08-07 | 2007-06-05 | Isis Pharmaceuticals, Inc. | Antisense modulation of apolipoprotein (a) expression |
CA2455424A1 (en) * | 2001-08-07 | 2003-02-20 | University Of Delaware | Compositions and methods for the prevention and treatment of huntington's disease |
US20030084473A1 (en) * | 2001-08-09 | 2003-05-01 | Valigen | Non-transgenic herbicide resistant plants |
US7456335B2 (en) * | 2001-09-03 | 2008-11-25 | Basf Plant Science Gmbh | Nucleic acid sequences and their use in methods for achieving pathogen resistance in plants |
ES2390531T3 (es) | 2001-09-18 | 2012-11-13 | Genentech, Inc. | Composiciones y procedimientos para el diagnósitco y tratamiento de tumor |
US20070136825A1 (en) | 2001-09-18 | 2007-06-14 | Wolf-Bernd Frommer | Fusion proteins useful for detecting analytes |
CA2461844C (en) | 2001-09-27 | 2011-04-05 | Pioneer Hi-Bred International, Inc. | Phytate polynucleotides and methods of use |
US7468244B2 (en) * | 2001-09-27 | 2008-12-23 | University Of Delaware | Polymorphism detection and separation |
AU2002341905A2 (en) * | 2001-09-27 | 2003-04-07 | University Of Delaware | Composition and methods for enhancing oligonucleotide-directed nucleic acid sequence alteration |
EP1448766A2 (en) * | 2001-09-27 | 2004-08-25 | University Of Delaware | Coisogenic eukaryotic cell collections |
NZ585001A (en) | 2001-10-09 | 2011-08-26 | Isis Pharmaceuticals Inc | Antisense modulation of insulin-like growth factor binding protein 5 expression |
US6750019B2 (en) | 2001-10-09 | 2004-06-15 | Isis Pharmaceuticals, Inc. | Antisense modulation of insulin-like growth factor binding protein 5 expression |
US6965025B2 (en) | 2001-12-10 | 2005-11-15 | Isis Pharmaceuticals, Inc. | Antisense modulation of connective tissue growth factor expression |
EP2067472A1 (en) | 2002-01-02 | 2009-06-10 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
IL152904A0 (en) | 2002-01-24 | 2003-06-24 | Gamida Cell Ltd | Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations |
EP1465982A4 (en) | 2002-01-25 | 2006-06-07 | Gamida Cell Ltd | PROCESS FOR EXPANSION OF STEM AND PRESERVATIVE CELLS AND EXPANDED CELL POPULATIONS THEREWITH OBTAINED |
JP2005515780A (ja) | 2002-02-01 | 2005-06-02 | セクイター インコーポレイテッド | 二本鎖オリゴヌクレオチド |
EP1572902B1 (en) | 2002-02-01 | 2014-06-11 | Life Technologies Corporation | HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES |
US20060009409A1 (en) | 2002-02-01 | 2006-01-12 | Woolf Tod M | Double-stranded oligonucleotides |
WO2003066836A2 (en) * | 2002-02-07 | 2003-08-14 | E. I. Du Pont De Nemours And Company | Udp-glucosyltransferases |
AU2003211128A1 (en) * | 2002-02-20 | 2003-09-09 | American Integrated Biologics, Inc. | Transgenic production in saliva |
JP2005518817A (ja) * | 2002-03-07 | 2005-06-30 | ユニバーシティー、オブ、デラウェア | ヒストン・デアセチラーゼ・インヒビタ、ラムダファージベータ蛋白、またはヒドロキシウレアを含む組成物を使用してオリゴヌクレオチド媒介性核酸配列改変を高める方法、組成物およびキット |
CA2481504C (en) | 2002-04-08 | 2011-08-23 | Pioneer Hi-Bred International, Inc. | Enhanced silk exsertion under stress |
US7244565B2 (en) * | 2002-04-10 | 2007-07-17 | Georgetown University | Gene shinc-3 and diagnostic and therapeutic uses thereof |
US7138512B2 (en) * | 2002-04-10 | 2006-11-21 | Georgetown University | Gene SHINC-2 and diagnostic and therapeutic uses thereof |
NZ535925A (en) | 2002-04-16 | 2008-06-30 | Genentech Inc | An isolated antibody that binds to a particular polypeptide |
US7432342B2 (en) | 2002-05-03 | 2008-10-07 | Sequenom, Inc. | Kinase anchor protein muteins, peptides thereof and related documents |
CA2484001A1 (en) | 2002-05-08 | 2003-11-20 | Basf Plant Science Gmbh | Methods for increasing oil content in plants |
US20030228317A1 (en) * | 2002-05-22 | 2003-12-11 | Prafulla Gokhale | Gene BRCC-1 and diagnostic and therapeutic uses thereof |
US7199107B2 (en) | 2002-05-23 | 2007-04-03 | Isis Pharmaceuticals, Inc. | Antisense modulation of kinesin-like 1 expression |
US20030228558A1 (en) * | 2002-06-11 | 2003-12-11 | Bloom William Dennis | Method of training brokers in a multi-level marketing business |
WO2003106617A2 (en) * | 2002-06-12 | 2003-12-24 | Tel Aviv Medical Center Research Development Fund | Oligonucleotides antibodies and kits including same for treating prostate cancer and determining predisposition thereto |
JPWO2004026343A1 (ja) * | 2002-09-20 | 2006-01-12 | 住友製薬株式会社 | 部位特異的遺伝子変換促進剤および遺伝子疾患治療剤 |
EP1549767A4 (en) | 2002-09-26 | 2006-06-07 | Amgen Inc | MODULATION OF FORKHEAD BOX O1A GENE EXPRESSION |
US20040175722A1 (en) * | 2002-10-07 | 2004-09-09 | Kmiec Eric B. | Methods and compositions for reducing screening in oligonucleotide-directed nucleic acid sequence alteration |
EP1560839A4 (en) | 2002-11-05 | 2008-04-23 | Isis Pharmaceuticals Inc | CHIMERIC OLIGOMER COMPOUNDS AND THEIR USE IN GENE MODULATION |
US9150605B2 (en) * | 2002-11-05 | 2015-10-06 | Isis Pharmaceuticals, Inc. | Compositions comprising alternating 2′-modified nucleosides for use in gene modulation |
EP1578765A4 (en) | 2002-11-05 | 2008-04-23 | Isis Pharmaceuticals Inc | OLIGOMERIC COMPOUNDS CONTAINING SUGAR SUBSTITUTE AND COMPOSITIONS FOR USE IN GENE MODULATION |
US9150606B2 (en) | 2002-11-05 | 2015-10-06 | Isis Pharmaceuticals, Inc. | Compositions comprising alternating 2'-modified nucleosides for use in gene modulation |
AU2003290689A1 (en) * | 2002-11-08 | 2004-06-03 | Kyowa Hakko Kirin Co., Ltd. | Transgenic ungulates having reduced prion protein activity and uses thereof |
EP1569695B1 (en) | 2002-11-13 | 2013-05-15 | Genzyme Corporation | Antisense modulation of apolipoprotein b expression |
DK2336318T3 (da) | 2002-11-13 | 2013-07-15 | Genzyme Corp | Antisense-modulering af apolipoprotein b-ekspression |
WO2004046330A2 (en) | 2002-11-15 | 2004-06-03 | Morphotek, Inc. | Methods of generating high-production of antibodies from hybridomas created by in vitro immunization |
US7144999B2 (en) | 2002-11-23 | 2006-12-05 | Isis Pharmaceuticals, Inc. | Modulation of hypoxia-inducible factor 1 alpha expression |
AU2003293991B2 (en) | 2002-12-19 | 2009-01-22 | Bayer Intellectual Property Gmbh | Plant cells and plants which synthesize a starch with an increased final viscosity |
CA2515484C (en) | 2003-02-11 | 2011-09-20 | Antisense Therapeutics Ltd | Modulation of insulin like growth factor i receptor expression |
EP1597371A2 (en) | 2003-02-17 | 2005-11-23 | Metanomics GmbH | Preparation of organisms with faster growth and/or higher yield |
US7803781B2 (en) | 2003-02-28 | 2010-09-28 | Isis Pharmaceuticals, Inc. | Modulation of growth hormone receptor expression and insulin-like growth factor expression |
US20040185559A1 (en) | 2003-03-21 | 2004-09-23 | Isis Pharmaceuticals Inc. | Modulation of diacylglycerol acyltransferase 1 expression |
CA2868312A1 (en) | 2003-03-31 | 2004-10-14 | University Of Bristol | Novel plant acyltransferases specific for long-chained, multiply unsaturated fatty acids |
US20040205840A1 (en) * | 2003-04-11 | 2004-10-14 | Pioneer Hi-Bred International, Inc. | Method for reducing gene expression |
EP1641930B1 (en) | 2003-04-15 | 2011-06-29 | BASF Plant Science GmbH | Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
US7598227B2 (en) | 2003-04-16 | 2009-10-06 | Isis Pharmaceuticals Inc. | Modulation of apolipoprotein C-III expression |
US7399853B2 (en) | 2003-04-28 | 2008-07-15 | Isis Pharmaceuticals | Modulation of glucagon receptor expression |
WO2005002507A2 (en) | 2003-06-03 | 2005-01-13 | Isis Pharmaceuticals, Inc. | Modulation of survivin expression |
WO2004113496A2 (en) * | 2003-06-20 | 2004-12-29 | Isis Pharmaceuticals, Inc. | Double stranded compositions comprising a 3’-endo modified strand for use in gene modulation |
CA2533701A1 (en) | 2003-07-31 | 2005-02-17 | Isis Pharmaceuticals, Inc. | Oligomeric compounds and compositions for use in modulation of small non-coding rnas |
BRPI0413073A (pt) | 2003-08-01 | 2006-10-03 | Basf Plant Science Gmbh | processo para a produção de compostos, óleo, lipìdeo ou ácido graxo, ou uma fração dos mesmos, composição de óleo, lipìdeo ou ácido graxo, processo para a produção de óleos, lipìdeos ou composições de ácido graxo, uso de óleo, lipìdeo ou ácidos graxos ou de composições de óleo, lipìdeo ou ácido graxo ou de óleos, lipìdeos ou composições de ácido graxo, seqüência de ácido nucleico isolado, seqüência de aminoácidos, construção de gene, vetor, e, organismo não humano transgênico |
EP1654368A2 (en) | 2003-08-01 | 2006-05-10 | BASF Plant Science GmbH | Process for the production of fine chemicals |
PT1654276E (pt) | 2003-08-11 | 2013-03-25 | Kweek En Researchbed Agrico Bv | Plantas resistentes a fungos e seus usos |
US7825235B2 (en) | 2003-08-18 | 2010-11-02 | Isis Pharmaceuticals, Inc. | Modulation of diacylglycerol acyltransferase 2 expression |
US20050053981A1 (en) | 2003-09-09 | 2005-03-10 | Swayze Eric E. | Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini |
AU2004274021B2 (en) | 2003-09-18 | 2009-08-13 | Isis Pharmaceuticals, Inc. | 4'-thionucleosides and oligomeric compounds |
EP2182063A3 (en) | 2003-09-18 | 2012-07-18 | Isis Pharmaceuticals, Inc. | Modulation of EIF4E expression |
EP1678194B1 (en) | 2003-10-10 | 2013-06-26 | Alchemia Oncology Pty Limited | The modulation of hyaluronan synthesis and degradation in the treatment of disease |
EP2267154A1 (en) | 2003-10-23 | 2010-12-29 | Illumigen Biosciences, Inc. | Oligoadenylate synthetase |
US20050191653A1 (en) | 2003-11-03 | 2005-09-01 | Freier Susan M. | Modulation of SGLT2 expression |
JP4901478B2 (ja) | 2003-11-17 | 2012-03-21 | ジェネンテック, インコーポレイテッド | 造血系起源の腫瘍の治療のための組成物と方法 |
US20050120397A1 (en) * | 2003-11-24 | 2005-06-02 | Hermann Steller | Compounds and methods for regulation of spermatid differentiation |
AU2004299669B2 (en) | 2003-12-17 | 2011-06-23 | Cropdesign N.V. | Plants having modified growth characteristics and method for making the same |
US7741070B2 (en) | 2003-12-24 | 2010-06-22 | Massachusetts Institute Of Technology | Gene targets for enhanced carotenoid production |
WO2005062923A2 (en) * | 2003-12-24 | 2005-07-14 | Massachusetts Institute Of Technology | Gene targets for enhanced carotenoid production |
US7608699B2 (en) * | 2003-12-29 | 2009-10-27 | Rockefeller University | Synthetic nuclear localization signal derived from lentiviral integrase and methods of use thereof |
EP1711606A2 (en) | 2004-01-20 | 2006-10-18 | Isis Pharmaceuticals, Inc. | Modulation of glucocorticoid receptor expression |
US7468431B2 (en) | 2004-01-22 | 2008-12-23 | Isis Pharmaceuticals, Inc. | Modulation of eIF4E-BP2 expression |
CN1942582A (zh) | 2004-02-25 | 2007-04-04 | 先锋高级育种国际公司 | 新的苏云金芽孢杆菌晶体多肽、多核苷酸及其组合物 |
EP3543324B1 (de) | 2004-02-27 | 2022-11-30 | BASF Plant Science GmbH | Verfahren zur herstellung mehrfach ungesättigten fettsäuren in transgenen pflanzen |
ES2375363T3 (es) | 2004-02-27 | 2012-02-29 | Basf Plant Science Gmbh | Método para la preparación de ácidos grasos omega-3 insaturados en organismos transgénicos. |
US8569474B2 (en) | 2004-03-09 | 2013-10-29 | Isis Pharmaceuticals, Inc. | Double stranded constructs comprising one or more short strands hybridized to a longer strand |
EP2700720A3 (en) | 2004-03-15 | 2015-01-28 | Isis Pharmaceuticals, Inc. | Compositions and methods for optimizing cleavage of RNA by RNASE H |
WO2005094370A2 (en) | 2004-03-29 | 2005-10-13 | The General Hospital Corporation | Oligonucleotide complex compositions and methods of use as gene alteration tools |
WO2005097817A2 (en) | 2004-04-05 | 2005-10-20 | Alnylam Pharmaceuticals, Inc. | Process and reagents for oligonucleotide synthesis and purification |
US20050244869A1 (en) | 2004-04-05 | 2005-11-03 | Brown-Driver Vickie L | Modulation of transthyretin expression |
JP2007533328A (ja) | 2004-04-22 | 2007-11-22 | キリンホールディングス株式会社 | トランスジェニック動物及びその用途 |
US20070072815A1 (en) * | 2004-05-04 | 2007-03-29 | Kmiec Eric B | Methods and kits to increase the efficiency of oligonucleotide-directed nucleic acid sequence alteration |
US7825293B2 (en) | 2004-05-28 | 2010-11-02 | Cropdesign N.V. | Plants having improved growth characteristics and a method for making the same |
US8394947B2 (en) | 2004-06-03 | 2013-03-12 | Isis Pharmaceuticals, Inc. | Positionally modified siRNA constructs |
CN101001957B (zh) | 2004-06-09 | 2012-07-04 | 先锋高级育种国际公司 | 质体转运肽 |
EP1765857A2 (en) | 2004-07-02 | 2007-03-28 | Metanomics GmbH | Process for the production of fine chemicals |
US8680062B2 (en) | 2004-07-06 | 2014-03-25 | Deliversir Ltd. | System for delivering therapeutic agents into living cells and cells nuclei |
EP1768997A1 (en) | 2004-07-12 | 2007-04-04 | CropDesign N.V. | Plants having improved growth characteristics and method for making the same |
WO2006013010A2 (en) | 2004-07-31 | 2006-02-09 | Metanomics Gmbh | Preparation of organisms with faster growth and/or higher yield |
DK2997980T3 (en) | 2004-08-10 | 2018-03-26 | Kastle Therapeutics Llc | PROCEDURES FOR MODULATING LIPROPROTEIN AND CHOLESTEROL LEVELS |
EP2166105A3 (en) | 2004-08-16 | 2010-04-14 | CropDesign N.V. | Plants having improved growth characteristics and method for making the same |
US7884086B2 (en) | 2004-09-08 | 2011-02-08 | Isis Pharmaceuticals, Inc. | Conjugates for use in hepatocyte free uptake assays |
EP1799812A4 (en) | 2004-09-16 | 2009-09-09 | Gamida Cell Ltd | EX VIVO CULTIVATION METHODS OF STEM CELLS AND PRECURSOR BY CO-CULTURE WITH MESENCHYMAL CELLS |
WO2006034348A2 (en) | 2004-09-17 | 2006-03-30 | Isis Pharmaceuticals, Inc. | Enhanced antisense oligonucleotides |
CA2579800A1 (en) | 2004-09-24 | 2006-03-30 | Basf Plant Science Gmbh | Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
CA2584614A1 (en) | 2004-10-20 | 2006-08-24 | Antisense Therapeutics Ltd | Antisense modulation of integrin .alpha.4 expression |
US20080108502A1 (en) | 2004-10-29 | 2008-05-08 | Cropdesign N.V. | Plants Having Improved Growth Characteristics And Method For Making The Same |
CA2585798A1 (en) | 2004-12-17 | 2006-06-17 | Metanomics Gmbh | Process for the control of production of fine chemicals |
AR051866A1 (es) | 2004-12-24 | 2007-02-14 | Cropdesign Nv | Plantas con aumento del rendimiento y metodo de prepracion |
EP2003205B1 (en) | 2004-12-28 | 2013-05-01 | Pioneer Hi-Bred International, Inc. | Improved grain quality through altered expression of seed proteins |
EP1844151A2 (en) | 2005-01-27 | 2007-10-17 | CropDesign N.V. | Plants having increased yield and a method for making the same |
BRPI0519985B1 (pt) | 2005-02-23 | 2018-01-30 | University Of Kentucky Research Foundation | Método para redução do nível de nornicotina ou n-nitrosonornicotina em uma planta do gênero nicotiana ou parte desta ou em um produto de tabaco, cassete de expressão e método para a produção de uma planta do gênero nicotiana |
EP2194140A2 (en) | 2005-03-02 | 2010-06-09 | Metanomics GmbH | Process for the production of fine chemicals |
EP2573188A2 (en) | 2005-03-02 | 2013-03-27 | Metanomics GmbH | Process for the production of fine chemicals |
ATE541043T1 (de) | 2005-03-08 | 2012-01-15 | Basf Plant Science Gmbh | Expressionsverstärkende intron-sequenz |
CN101175769A (zh) | 2005-03-10 | 2008-05-07 | 健泰科生物技术公司 | 用于调控血管完整性的方法和组合物 |
DE102005013779A1 (de) | 2005-03-22 | 2006-09-28 | Basf Plant Science Gmbh | Verfahren zur Herstellung von mehrfach ungesättigten C20- und C22-Fettsäuren mit mindestens vier Doppelbindungen in transgenen Pflanzen |
EP1707632A1 (de) | 2005-04-01 | 2006-10-04 | Bayer CropScience GmbH | Phosphorylierte waxy-Kartoffelstärke |
WO2006111512A1 (en) | 2005-04-19 | 2006-10-26 | Basf Plant Science Gmbh | Improved methods controlling gene expression |
WO2006113666A2 (en) | 2005-04-19 | 2006-10-26 | Massachusetts Institute Of Technology | Amphiphilic polymers and methods of use thereof |
US20070011752A1 (en) * | 2005-05-06 | 2007-01-11 | American Integrated Biologics, Inc. | Production of human proteins in transgenic animal saliva |
US20060272057A1 (en) | 2005-05-25 | 2006-11-30 | Pioneer Hi-Bred International, Inc. | Methods for improving crop plant architecture and yield |
WO2007008300A2 (en) | 2005-05-31 | 2007-01-18 | ECOLE POLYTECHNIQUE FéDéRALE DE LAUSANNE | Triblock copolymers for cytoplasmic delivery of gene-based drugs |
WO2006138145A1 (en) | 2005-06-14 | 2006-12-28 | Northwestern University | Nucleic acid functionalized nanoparticles for therapeutic applications |
US7994399B2 (en) | 2005-06-23 | 2011-08-09 | Basf Plant Science Gmbh | Methods for the production of stably transformed, fertile Zea mays plants |
EP2431472A1 (en) | 2005-07-06 | 2012-03-21 | CropDesign N.V. | Plant yield improvement by STE20-like gene expression |
DE102005038036A1 (de) | 2005-08-09 | 2007-02-15 | Basf Plant Science Gmbh | Verfahren zur Herstellung von Arachidonsäure und/oder Eicosapentaensäure in transgenen Nutzpflanzen |
EP1915452A2 (en) | 2005-08-12 | 2008-04-30 | BASF Plant Science GmbH | Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
US7842856B2 (en) | 2005-08-25 | 2010-11-30 | The Board Of Trustees Of The University Of Illinois | Herbicide resistance gene, compositions and methods |
WO2007031581A2 (en) | 2005-09-15 | 2007-03-22 | Cropdesign N.V. | Plant yield improvement by group 3 lea expression |
EP2980220A1 (en) | 2005-09-20 | 2016-02-03 | BASF Plant Science GmbH | Improved methods controlling gene expression |
GB2431158A (en) | 2005-10-13 | 2007-04-18 | Rothamsted Res Ltd | Process for the production of arachidonic and/or eicosapentaenoic acid |
US8853492B2 (en) | 2005-11-07 | 2014-10-07 | Cropdesign N.V. | Plants having improved growth characteristics and a method for making the same |
EP2333089A1 (en) | 2005-11-07 | 2011-06-15 | CropDesign N.V. | Class I homeodomain leucine zipper (HDZip) hox5 polypetide-expressing plants having improved growth characteristics and a method for making the same |
US20090222952A1 (en) | 2005-11-08 | 2009-09-03 | Cropdesign N.V. | Plants Having Improved Growth Characteristics And A Method For Making The Same |
CA2628505A1 (en) | 2005-11-08 | 2007-05-18 | Basf Plant Science Gmbh | Use of armadillo repeat (arm1) polynucleotides for obtaining resistance to pathogens in plants |
JP2009515522A (ja) | 2005-11-10 | 2009-04-16 | パイオニア ハイ−ブレッド インターナショナル, インコーポレイテッド | Dof(dnabindingwithonefinger)配列および使用方法 |
US20070199096A1 (en) | 2005-11-14 | 2007-08-23 | E.I. Du Pont De Nemours And Company | Compositions and Methods for Altering Alpha- and Beta-Tocotrienol Content |
JP2009516710A (ja) | 2005-11-21 | 2009-04-23 | アイシス ファーマシューティカルズ, インコーポレーテッド | eIF4E−BP2の発現のモジュレート |
US7723574B2 (en) | 2005-11-24 | 2010-05-25 | Basf Plant Science Gmbh | Process for the production of Δ5-unsaturated fatty acids in transgenic organisms |
WO2007060117A2 (de) * | 2005-11-24 | 2007-05-31 | Basf Se | Chimäre keratinbindende effektorproteine |
US8846393B2 (en) | 2005-11-29 | 2014-09-30 | Gamida-Cell Ltd. | Methods of improving stem cell homing and engraftment |
EP2166086A3 (en) | 2005-12-01 | 2010-10-20 | CropDesign N.V. | Plants having improved growth characteristics and methods for making the same |
JP2009521213A (ja) | 2005-12-24 | 2009-06-04 | ティーガスク デイリー プロダクツ リサーチ センター | トランス−10,シス−12オクタデカジエン酸を製造する方法 |
CN101437933B (zh) | 2005-12-28 | 2013-11-06 | 斯克里普斯研究所 | 作为药物靶标的天然反义和非编码的rna转录物 |
US7592505B2 (en) | 2005-12-30 | 2009-09-22 | Pioneer Hi-Bred International, Inc. | UDP-xylose synthases (UXS) polynucleotides, polypeptides, and uses thereof |
NZ704098A (en) | 2006-01-12 | 2015-02-27 | Incima Ipco B V | Epsps mutants |
EP2380986A1 (en) | 2006-01-12 | 2011-10-26 | BASF Plant Science GmbH | Use of stomatin (STM1) polynucleotides for achieving a pathogen resistance in plants |
PT2161038E (pt) | 2006-01-26 | 2014-03-10 | Isis Pharmaceuticals Inc | Composições e suas utilizações dirigidas à huntingtina |
US8129515B2 (en) | 2006-01-27 | 2012-03-06 | Isis Pharmaceuticals, Inc. | Oligomeric compounds and compositions for the use in modulation of microRNAs |
US7569686B1 (en) | 2006-01-27 | 2009-08-04 | Isis Pharmaceuticals, Inc. | Compounds and methods for synthesis of bicyclic nucleic acid analogs |
EP2314594B1 (en) | 2006-01-27 | 2014-07-23 | Isis Pharmaceuticals, Inc. | 6-modified bicyclic nucleic acid analogs |
AU2007212168A1 (en) | 2006-02-09 | 2007-08-16 | Pioneer Hi-Bred International, Inc. | Genes for enhancing nitrogen utilization efficiency in crop plants |
GB0603160D0 (en) | 2006-02-16 | 2006-03-29 | Rothamsted Res Ltd | Nucleic acid |
EP2343377A3 (en) | 2006-03-24 | 2011-11-16 | BASF Plant Science GmbH | Proteins associated with abiotic stress response and homologs |
EP2199398A1 (en) | 2006-03-31 | 2010-06-23 | BASF Plant Science GmbH | Plants having enhanced yield-related traits and a method for making the same |
AU2007299219A1 (en) | 2006-04-05 | 2008-03-27 | Metanomics Gmbh | Process for the production of a fine chemical |
EP2251349A1 (en) | 2006-04-19 | 2010-11-17 | Pioneer Hi-Bred International, Inc. | Isolated polynucleotide molecules corresponding to mutant and wild-type alleles of the maize D9 gene and methods of use |
US20090326041A1 (en) | 2006-05-05 | 2009-12-31 | Isis Pharmaceuticals, Inc. | Compounds and methods for modulating expression of sglt2 |
US7666854B2 (en) | 2006-05-11 | 2010-02-23 | Isis Pharmaceuticals, Inc. | Bis-modified bicyclic nucleic acid analogs |
DK2066684T3 (da) | 2006-05-11 | 2012-10-22 | Isis Pharmaceuticals Inc | 5´-Modificerede bicycliske nukleinsyreanaloge |
EP2035562A2 (en) | 2006-05-30 | 2009-03-18 | CropDesign N.V. | Plants with modulated expression of extensin receptor-like kinase having enhanced yield-related traits and a method for making the same |
CA2651961A1 (en) | 2006-05-31 | 2007-12-06 | Metanomics Gmbh | Manipulation of the nitrogen metabolism |
US9506056B2 (en) | 2006-06-08 | 2016-11-29 | Northwestern University | Nucleic acid functionalized nanoparticles for therapeutic applications |
CN103215288A (zh) | 2006-06-08 | 2013-07-24 | 巴斯福植物科学有限公司 | 具有改良生长特性的植物及其制备方法 |
KR101105330B1 (ko) | 2006-06-15 | 2012-01-18 | 재단법인 작물유전체기능연구사업단 | Nac 전사인자의 발현 조절로 향상된 수확량 관련 형질을갖는 식물 및 이의 제조 방법 |
EP2599870A3 (en) | 2006-06-15 | 2013-09-11 | CropDesign N.V. | Plants having enhanced yield-related traits and a method for making the same |
NZ574390A (en) | 2006-06-28 | 2012-04-27 | Coh Inc | Fatty acid blends and uses therefor in fuel |
US8198253B2 (en) | 2006-07-19 | 2012-06-12 | Isis Pharmaceuticals, Inc. | Compositions and their uses directed to HBXIP |
EP2543732A1 (en) | 2006-08-02 | 2013-01-09 | CropDesign N.V. | Plants transformed with a nucleic acid encoding chloroplastic fructose-1,6-bisphosphatase having increased yield, and a method for making the same |
CN104099368A (zh) | 2006-08-02 | 2014-10-15 | 克罗普迪塞恩股份有限公司 | 具有改良特征的植物及其制备方法 |
RU2428480C9 (ru) | 2006-08-30 | 2012-03-20 | Басф Плант Сайенс Гмбх | Способ повышения резистентности трансгенных растений к патогенным воздействиям |
US8454948B2 (en) | 2006-09-14 | 2013-06-04 | Medgenics Medical Israel Ltd. | Long lasting drug formulations |
AU2007294858B2 (en) | 2006-09-14 | 2011-05-12 | Medgenics Medical Israel, Ltd | Long lasting drug formulations |
CA2847007C (en) | 2006-10-06 | 2016-11-08 | Basf Plant Science Gmbh | Process for the production of polyunsaturated fatty acids in transgenic organisms |
US8329988B2 (en) | 2006-10-12 | 2012-12-11 | Basf Plant Science Gmbh | Method for increasing pathogen resistance in transgenic plants |
CN101589148B (zh) | 2006-10-13 | 2014-07-02 | 巴斯福植物科学有限公司 | 产量提高的植物 |
EP2081954B1 (de) | 2006-10-24 | 2012-06-13 | BASF Plant Science GmbH | Verfahren zur erhöhung der resistenz gegen biotrophe pilze in pflanzen |
AR064252A1 (es) | 2006-11-16 | 2009-03-25 | Cropdesign Nv | Plantas que presentan caracteristicas acrecentadas relacionadas con el rendimiento y un metodo para producir las mismas |
WO2008062049A1 (en) | 2006-11-24 | 2008-05-29 | Cropdesign N.V. | Transgenic plants comprising as transgene a class i tcp or clavata 1 (clv1) or cah3 polypeptide having increased seed yield and a method for making the same |
US20100024067A1 (en) | 2006-12-15 | 2010-01-28 | Cropdesign N.V. | Plants having enhanced seed yield-related traits and a method for making the same |
WO2008074891A2 (en) | 2006-12-21 | 2008-06-26 | Basf Plant Science Gmbh | Plants having enhanced yield-related traits and a method for method for making the same |
EP1935428A1 (en) * | 2006-12-22 | 2008-06-25 | Antisense Pharma GmbH | Oligonucleotide-polymer conjugates |
ES2711627T3 (es) | 2006-12-28 | 2019-05-06 | Pioneer Hi Bred Int | Marcadores genéticos para resistencia a orobanca en girasol |
CA2689296C (en) * | 2007-01-10 | 2015-11-17 | Purdue Research Foundation | Polypeptide inhibitors of hsp27 kinase and uses therefor |
WO2008087141A2 (en) | 2007-01-15 | 2008-07-24 | Basf Plant Science Gmbh | Use of subtilisin (rnr9) polynucleotides for achieving a pathogen resistance in plants |
MX2009007246A (es) | 2007-01-30 | 2009-09-16 | Cropdesign Nv | Plantas con rasgos relacionados con el rendimiento mejorado y un metodo para producirlas. |
WO2008092935A2 (en) | 2007-01-31 | 2008-08-07 | Basf Plant Science Gmbh | Plants having enhanced yield-related traits and/or increased abiotic stress resistance, and a method for making the same |
EP2121987B1 (en) | 2007-02-09 | 2012-06-13 | Northwestern University | Particles for detecting intracellular targets |
CA2679077A1 (en) | 2007-02-28 | 2008-09-04 | Cropdesign N.V. | Plants having enhanced yield-related traits and a method for making the same |
US8153863B2 (en) | 2007-03-23 | 2012-04-10 | New York University | Transgenic plants expressing GLK1 and CCA1 having increased nitrogen assimilation capacity |
UA126227C2 (uk) | 2007-04-04 | 2022-09-07 | Басф Плант Саєнс Гмбх | Злакова рослина, толерантна до імідозолінону або сульфонілсечовини |
PT2144633E (pt) * | 2007-04-23 | 2014-10-27 | Deliversir Ltd | Um sistema para a administração de agentes terapêuticos em células vivas e núcleos de células |
US9556210B2 (en) | 2007-04-23 | 2017-01-31 | Sabag-Rfa Ltd. | System for delivering therapeutic agents into living cells and cells nuclei |
US9156865B2 (en) | 2007-04-23 | 2015-10-13 | Deliversir Ltd | System for delivering therapeutic agents into living cells and cells nuclei |
ES2542311T3 (es) | 2007-05-03 | 2015-08-04 | Basf Plant Science Gmbh | Plantas que tienen rasgos potenciados relacionados con el rendimiento y un procedimiento de producción de las mismas |
EP2821493A1 (en) | 2007-05-22 | 2015-01-07 | BASF Plant Science GmbH | Plants with increased tolerance and/or resistance to environmental stress and increased biomass production |
US20100162432A1 (en) | 2007-05-22 | 2010-06-24 | Basf Plant Science Gmbh | Plant cells and plants with increased tolerance and/or resistance to environmental stress and increased biomass production-ko |
MX2009012451A (es) | 2007-05-23 | 2009-12-02 | Cropdesign Nv | Plantas con rasgos mejorados relacionados con el rendimiento y un metodo para producirlas. |
WO2008145629A2 (en) | 2007-05-25 | 2008-12-04 | Cropdesign N.V. | Yield enhancement in plants by modulation of maize alfins |
AU2008260277C1 (en) | 2007-05-30 | 2014-04-17 | Isis Pharmaceuticals, Inc. | N-substituted-aminomethylene bridged bicyclic nucleic acid analogs |
DK2173760T4 (en) | 2007-06-08 | 2016-02-08 | Isis Pharmaceuticals Inc | Carbocyclic bicyclic nukleinsyreanaloge |
US20100199380A1 (en) | 2007-06-29 | 2010-08-05 | Basf Plant Science Gmbh | Plants having enhanced yield-related traits and a method for making the same |
ES2376507T5 (es) | 2007-07-05 | 2015-08-31 | Isis Pharmaceuticals, Inc. | Análogos de ácidos nucleicos bicíclicos 6-disustituidos |
CN102827865A (zh) | 2007-07-20 | 2012-12-19 | 巴斯夫植物科学有限公司 | 具有增强的产率相关性状的植物及其制备方法 |
EP2503000A1 (en) | 2007-07-31 | 2012-09-26 | BASF Plant Science GmbH | Plants having enhanced yield-related traits and a method for making the same |
AR067748A1 (es) | 2007-07-31 | 2009-10-21 | Basf Plant Science Gmbh | Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para obtenerlas |
WO2009021137A2 (en) * | 2007-08-07 | 2009-02-12 | Purdue Research Foundation | Kinase inhibitors and uses thereof |
EP2188298B1 (en) | 2007-08-15 | 2013-09-18 | Isis Pharmaceuticals, Inc. | Tetrahydropyran nucleic acid analogs |
EP2537940A3 (en) | 2007-09-14 | 2013-04-10 | BASF Plant Science GmbH | Plants having increased yield-related traits and a method for making the same |
DE112008002435T5 (de) | 2007-09-18 | 2010-07-22 | Basf Plant Science Gmbh | Pflanzen mit erhöhtem Ertrag |
WO2009039442A1 (en) | 2007-09-21 | 2009-03-26 | California Institute Of Technology | Nfia in glial fate determination, glioma therapy and astrocytoma treatment |
JP2010538670A (ja) | 2007-09-21 | 2010-12-16 | ビーエーエスエフ プラント サイエンス ゲーエムベーハー | 増強された収穫高関連形質を有する植物およびその作製方法 |
AU2008300548B2 (en) | 2007-09-21 | 2015-04-09 | Basf Plant Science Gmbh | Plants with increased yield |
US20100280098A1 (en) * | 2007-10-05 | 2010-11-04 | Juliano Rudolph L | Receptor targeted oligonucleotides |
EA026107B1 (ru) | 2007-10-05 | 2017-03-31 | СИБАС ЕУРОП Би.Ви. | СОДЕРЖАЩИЕ МУТАЦИИ ГЕНЫ СИНТАЗЫ АЦЕТОГИДРОКСИКИСЛОТ РАСТЕНИЯ Brassica И ИХ ПРИМЕНЕНИЕ |
US20110071047A1 (en) * | 2007-10-27 | 2011-03-24 | O.D. 260 Inc. | Promoter detection and analysis |
US20090111099A1 (en) * | 2007-10-27 | 2009-04-30 | Yongsheng Ma | Promoter Detection and Analysis |
EP2235183A2 (en) | 2007-10-29 | 2010-10-06 | BASF Plant Science GmbH | Plants having enhanced yield-related traits and a method for making the same |
BRPI0820042B1 (pt) | 2007-11-12 | 2020-05-19 | North Carolina State University | método de obtenção de uma planta de tabaco, ou célula ou parte desta, tendo níveis reduzidos de nornicotina, produto de tabaco, método para fabricar um produto de tabaco, polinucleotídeo isolado, cassete de expressão, polipetpídeo isolado e método de obtenção de uma planta, ou parte de planta desta, do gênero nicotiana |
WO2009064920A2 (en) | 2007-11-13 | 2009-05-22 | Isis Pharmaceuticals, Inc. | Compounds and methods for modulating protein expression |
WO2009067580A2 (en) | 2007-11-20 | 2009-05-28 | Pioneer Hi-Bred International, Inc. | Maize ethylene signaling genes and modulation of same for improved stress tolerance in plants |
EP2222851B1 (en) | 2007-11-20 | 2017-06-28 | Ionis Pharmaceuticals, Inc. | Modulation of cd40 expression |
WO2009067647A1 (en) * | 2007-11-21 | 2009-05-28 | Isis Pharmaceuticals, Inc. | Carbocyclic alpha-l-bicyclic nucleic acid analogs |
CN103773795A (zh) | 2007-11-22 | 2014-05-07 | 克罗普迪塞恩股份有限公司 | 具有增强的产量相关性状的植物及其生产方法 |
EP2581385A1 (en) | 2007-11-26 | 2013-04-17 | BASF Plant Science GmbH | Plants having enhanced yield-related traits and a method for making the same |
AR069893A1 (es) | 2007-12-19 | 2010-02-24 | Basf Plant Science Gmbh | Plantas con mayor rendimiento y/o mayor tolerancia al estres ambiental (iy-bm) |
AU2008339968A1 (en) | 2007-12-20 | 2009-07-02 | Basf Plant Science Gmbh | Plants having enhanced yield-related traits and a method for making the same |
BRPI0821009A2 (pt) | 2007-12-21 | 2019-09-24 | Basf Plant Science Gmbh | métodos para aumentar o rendimento de uma planta e para produzir uma célula de planta transgênica, uma planta ou uma parte e para determinar o teor de nitrogênio de solo de teste, moléculas, moléculas de ácido nucléico isolada e de ácido nucleico viral, oligoiniciador, mutante negativo dominante de polipeptideo, construto de ácido nucleico, vetor, célula de planta transgênica, planta ou uma parte da mesma, polipeptideo, anticorpo, tecido de planta, planta, material de planta colhida ou material de propagação de uma planta, processo para produzir um polipeptideo, composição de alimento ou ração, e, uso |
JP2011508047A (ja) * | 2007-12-27 | 2011-03-10 | サイバス,エルエルシー | アルキルエステル脂肪酸配合物およびその用途 |
EP2599874A3 (en) | 2008-01-25 | 2013-11-13 | BASF Plant Science GmbH | Plants having enhanced yield-related traits and a method for making the same |
BRPI0906719A2 (pt) | 2008-01-31 | 2015-08-04 | Nat Inst For Biolog Sciences | Método para alterar o crescimento e/ou desenvolvimento de planta, construção, uso de uma construção, planta, parte de planta ou célula de planta, método para a produção de uma planta transgênica, partes colhíveis de uma planta, produtos derivados de uma planta, e, uso de um ácido nucleico. |
WO2009100320A2 (en) | 2008-02-07 | 2009-08-13 | Isis Pharmaceuticals, Inc. | Bicyclic cyclohexitol nucleic acid analogs |
AU2009218478A1 (en) | 2008-02-27 | 2009-09-03 | Basf Plant Science Gmbh | Plants with increased yield |
US8426378B2 (en) | 2008-03-21 | 2013-04-23 | Isis Pharmaceuticals, Inc. | Oligomeric compounds comprising tricyclic nucelosides and methods for their use |
DK2285819T3 (da) | 2008-04-04 | 2013-12-02 | Isis Pharmaceuticals Inc | Oligomere forbindelser omfattende neutralt bundne, terminale bicykliske nukleosider |
AR073534A1 (es) | 2008-04-16 | 2010-11-17 | Basf Plant Science Gmbh | Plantas que tienen rasgos aumentados relacionados con el rendimiento y un metodo para obtenerlas |
BRPI0912244A2 (pt) | 2008-05-05 | 2016-10-11 | Basf Plant Science Gmbh | método para intensificar as características relacionadas com o rendimento em plantas em relação às plantas de controle, constructo, uso do mesmo, planta, parte de planta ou célula de planta, método para a produção de uma planta transgênica, planta transgênica, partes colhíveis de uma planta, produtos, e, uso de um ácido nucleico. |
WO2009143490A1 (en) | 2008-05-23 | 2009-11-26 | Cibus International, L.P. | Production of squalene using yeast |
AU2009259433A1 (en) | 2008-06-20 | 2009-12-23 | Basf Plant Science Gmbh | Plants having enhanced yield-related traits and a method for making the same |
EP2975130A3 (en) | 2008-06-26 | 2016-04-20 | BASF Plant Science GmbH | Plants having enhanced yield-related traits and a method for making the same |
BRPI0914602A2 (pt) | 2008-07-04 | 2015-12-15 | Basf Plant Science Gmbh | método para intensificar características relacionadas a rendimento em plantas em relação a plantas de controle, e para a produção de uma planta transgênica, molécula de ácido nucleico isolada, polipeptídeo isolado, construção, usos de uma construção e de um ácido nucleico, planta, partes de uma planta ou célula de planta, partes colhíveis de uma plantas ,e , produtos. |
WO2010007035A1 (en) | 2008-07-17 | 2010-01-21 | Basf Plant Science Gmbh | Plants having enhanced yield-related traits and a method for making the same |
MX2011000778A (es) | 2008-07-31 | 2011-03-15 | Basf Plant Science Gmbh | Plantas con caracteristicas modificadas de crecimiento y un metodo para obtenerlas. |
WO2010017248A2 (en) | 2008-08-04 | 2010-02-11 | University Of Miami | Sting (stimulator of interferon genes), a regulator of innate immune responses |
US20110154530A1 (en) | 2008-08-19 | 2011-06-23 | Basf Plant Science Gmbh | Plants with Increased Yield by Increasing or Generating One or More Activities in a Plant or a Part Thereof |
EP2315774A1 (en) | 2008-08-20 | 2011-05-04 | BASF Plant Science GmbH | Plants having enhanced yield-related traits and a method for making the same |
EP3081648A1 (en) | 2008-08-25 | 2016-10-19 | Excaliard Pharmaceuticals, Inc. | Antisense oligonucleotides directed against connective tissue growth factor and uses thereof |
CN102159711B (zh) | 2008-09-11 | 2014-01-29 | 凯津公司 | 形成鉴别标记物的方法 |
EP2337853A1 (en) | 2008-09-23 | 2011-06-29 | BASF Plant Science Company GmbH | Plants with increased yield (lt) |
US8501805B2 (en) | 2008-09-24 | 2013-08-06 | Isis Pharmaceuticals, Inc. | Substituted alpha-L-bicyclic nucleosides |
BRPI0918991A2 (pt) | 2008-09-24 | 2017-09-19 | Basf Plant Science Gmbh | Métodos para intensificar traços relacionados com o rendimento em plantas em relação ás plantas de controle, e para produzir uma planta transgênica, planta, parte de planta ou célula de planta, construção, uso de uma construção, partes colhíveis de uma planta, produtos, uso em um ácido nucleico, molécula de ácido nucleico isolada, e, polipeptídeo isolado |
EP2361256B1 (en) | 2008-09-24 | 2013-04-10 | Isis Pharmaceuticals, Inc. | Cyclohexenyl nucleic acid analogs |
PL2733212T3 (pl) | 2008-09-26 | 2019-06-28 | Basf Agrochemical Products, B.V. | Mutanty ahas odporne na herbicyd i sposoby ich zastosowania |
AU2009305636A1 (en) | 2008-10-15 | 2010-04-22 | Ionis Pharmaceuticals, Inc. | Modulation of Factor 11 expression |
ES2507496T3 (es) * | 2008-10-20 | 2014-10-15 | Moerae Matrix, Inc. | Polipéptido para tratar o evitar adherencias |
AR075466A1 (es) | 2008-10-22 | 2011-04-06 | Basf Se | Uso de herbicidas tipo auxina en plantas cultivadas |
AR075465A1 (es) | 2008-10-22 | 2011-04-06 | Basf Se | Uso de herbicidas de sulfonilurea en plantas cultivadas |
CN102264907A (zh) | 2008-10-23 | 2011-11-30 | 巴斯夫植物科学有限公司 | 产量增加的植物(nue) |
BRPI0919684A2 (pt) | 2008-10-23 | 2014-02-04 | Basf Plant Science Gmbh | Métodos para produzir uma célula transgênica, e uma composição agrícola, molécula de ácido nucleico isolada, construção de ácido nucleico, vetor, célula hospedeira, processos para produzir um polipeptídeo, e para identificar um composto, polipeptídeo, anticorpo, núcleo de célula, tecido vegetal de célula vegetal, material de propagação, pólen, progênie, material coletado ou uma planta, planta transgênica, núcleo de célula de planta transgênica, célula de planta transgênica, planta, composição, e, uso de uma molécula de ácido nucleico |
EP2447274B1 (en) | 2008-10-24 | 2017-10-04 | Ionis Pharmaceuticals, Inc. | Oligomeric compounds and methods |
AU2009308217B2 (en) | 2008-10-24 | 2016-01-21 | Ionis Pharmaceuticals, Inc. | 5' and 2' bis-substituted nucleosides and oligomeric compounds prepared therefrom |
EP2821490A3 (en) | 2008-10-30 | 2015-04-22 | Pioneer Hi-Bred International Inc. | Manipulation of glutamine synthetases (GS) to improve nitrogen use efficiency and grain yield in higher plants |
EP2184351A1 (en) | 2008-10-30 | 2010-05-12 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Polynucleotides encoding caryophyllene synthase and uses thereof |
CN102272309A (zh) | 2008-11-12 | 2011-12-07 | 巴斯夫植物科学有限公司 | 具有增强的非生物胁迫耐受性和/或增强的产量相关性状的植物及其制备方法 |
WO2010054513A1 (en) | 2008-11-14 | 2010-05-20 | Fujian Fuda Biotech Co. Ltd. | A thermotolerant non-k12 escherichia coli phytase and its production |
DK2365803T3 (en) | 2008-11-24 | 2018-01-22 | Univ Northwestern | POLYVALENT RNA NANOPARTICLE COMPOSITIONS |
BRPI0922553A2 (pt) | 2008-12-03 | 2013-05-07 | Basf Plant Science Gmbh | mÉtodo para aumentar a tolerÂncia a estresse abiàtico e/ou para aumentar uma caracterÍstica relacionada ao rendimento em uma planta, construto, planta, cÉlula de planta ou parte da mesma, incluindo sementes, partes cultivÁveis da dita planta, produtos derivados de dita planta e/ou de ditas partes cultivÁveis, mÉtodo para a produÇço de plantas transgÊnicas, uso de um construto ou de um Ácido nucleico, molÉcula de Ácido nucleico isolada, e, polipeptÍdeo isolado |
WO2010065792A2 (en) | 2008-12-04 | 2010-06-10 | Curna, Inc. | Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo |
WO2010065867A1 (en) | 2008-12-04 | 2010-06-10 | Pioneer Hi-Bred International, Inc. | Methods and compositions for enhanced yield by targeted expression of knotted1 |
ES2637063T3 (es) | 2008-12-04 | 2017-10-10 | Curna, Inc. | Tratamiento de enfermedades relacionadas con genes supresores de tumor mediante inhibición del transcrito antisentido natural al gen |
MX366774B (es) | 2008-12-04 | 2019-07-24 | Curna Inc | Uso de oligonucleótidos antisentido en la inhibición de transcrito antisentido natural para sirtuina 1. |
CN105920582B (zh) | 2008-12-10 | 2020-04-14 | 普渡研究基金会 | 基于细胞渗透性肽的激酶抑制剂 |
ES2435572T3 (es) | 2008-12-12 | 2013-12-20 | Basf Plant Science Gmbh | Desaturasas y proceso para la producción de ácidos grasos poliinsaturados en organismos transgénicos |
AU2009328306A1 (en) | 2008-12-17 | 2011-07-14 | Basf Plant Science Gmbh | Plants having enhanced yield-related traits and/or abiotic stress tolerance and a method for making the same |
CA2746508A1 (en) | 2008-12-17 | 2010-07-15 | Avi Biopharma, Inc. | Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis |
EP2204086A1 (en) | 2009-01-02 | 2010-07-07 | Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung (IPK) | Six row-type barley |
US20100233270A1 (en) | 2009-01-08 | 2010-09-16 | Northwestern University | Delivery of Oligonucleotide-Functionalized Nanoparticles |
WO2010083328A2 (en) | 2009-01-14 | 2010-07-22 | The Salk Institute For Biological Studies | Methods for screening and compounds that protect against amyloid diseases |
AU2010209875A1 (en) | 2009-01-28 | 2011-08-18 | Basf Plant Science Company Gmbh | Plants having enhanced yield-related traits and a method for making the same |
EP2393825A2 (en) | 2009-02-06 | 2011-12-14 | Isis Pharmaceuticals, Inc. | Oligomeric compounds and methods |
WO2010090969A1 (en) | 2009-02-06 | 2010-08-12 | Isis Pharmaceuticals, Inc. | Tetrahydropyran nucleic acid analogs |
PL2396038T3 (pl) | 2009-02-12 | 2016-05-31 | Curna Inc | Leczenie chorób związanych z neurotropowym czynnikiem pochodzenia mózgowego (bdnf) poprzez zahamowanie naturalnego antysensownego transkryptu bdnf |
US20110319476A1 (en) | 2009-02-12 | 2011-12-29 | Opko Curna, Llc | Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf |
BRPI1008725A2 (pt) | 2009-02-25 | 2016-03-08 | Basf Plant Science Co Gmbh | métodos para intensificar e melhorar características relacionadas ao rendimento em plantas com relação às plantas de controle, e para a produção de uma planta transgênica, construto, usos do construto, de um ácido nucleico, e de uma sequência de ácido nucleic, planta, parte da planta ou célula da planta, planta transgênica, partes colhíveis, produtos, molécula de ácido nucleico isolada, e, polipeptídeo isolado |
WO2010101818A1 (en) | 2009-03-02 | 2010-09-10 | Pioneer Hi-Bred International, Inc. | Nac transcriptional activators involved in abiotic stress tolerance |
EP2403946A4 (en) | 2009-03-04 | 2012-11-14 | TREATMENT OF SIRTUIN 1 (SIRT1) -HANDLED ILLNESSES BY INHIBITING THE NATURAL ANTISENSE TRANSCRIPT AGAINST SIRT 1 | |
US9464287B2 (en) | 2009-03-16 | 2016-10-11 | Curna, Inc. | Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases by inhibition of natural antisense transcript to NRF2 |
CA2755404C (en) | 2009-03-17 | 2020-03-24 | Joseph Collard | Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1 |
EP2419510B1 (en) | 2009-04-14 | 2015-09-16 | Pioneer Hi-Bred International Inc. | Modulation of acc synthase improves plant yield under low nitrogen conditions |
WO2010121956A1 (en) | 2009-04-21 | 2010-10-28 | Basf Plant Science Company Gmbh | Rna-mediated induction of gene expression in plants |
WO2010121952A1 (en) | 2009-04-21 | 2010-10-28 | Basf Plant Science Company Gmbh | Rna-mediated induction of gene expression in plants |
EP3248618A1 (en) | 2009-04-22 | 2017-11-29 | Massachusetts Institute Of Technology | Innate immune suppression enables repeated delivery of long rna molecules |
WO2010125036A2 (en) | 2009-04-29 | 2010-11-04 | Basf Plant Science Company Gmbh | Plants having enhanced yield-related traits and a method for making the same |
MX2011011453A (es) | 2009-04-29 | 2011-11-18 | Basf Plant Science Co Gmbh | Plantas que tienen mejores rasgos relacionados con el rendimiento y un metodo para producirlas. |
US8318690B2 (en) | 2009-05-01 | 2012-11-27 | Curna, Inc. | Treatment of hemoglobin (HBF/HBG) related diseases by inhibition of natural antisense transcript to HBF/HBG |
EP2666781A1 (en) | 2009-05-04 | 2013-11-27 | Pioneer Hi-Bred International, Inc. | Yield enhancement in plants by modulation of AP2 transcription factor |
CA2760754A1 (en) | 2009-05-06 | 2010-11-11 | Basf Plant Science Company Gmbh | Plants having enhanced yield-related traits and/or enhanced abiotic stress tolerance and a method for making the same |
CN106237345A (zh) | 2009-05-06 | 2016-12-21 | 库尔纳公司 | 通过针对脂质转运和代谢基因的天然反义转录物的抑制治疗脂质转运和代谢基因相关疾病 |
ES2609655T3 (es) | 2009-05-06 | 2017-04-21 | Curna, Inc. | Tratamiento de enfermedades relacionadas con tristetraprolina (TTP) mediante inhibición de transcrito antisentido natural para TTP |
JP5922017B2 (ja) | 2009-05-18 | 2016-05-24 | クルナ・インコーポレーテッド | リプログラミング因子に対する天然アンチセンス転写物の抑制によるリプログラミング因子関連疾患の治療 |
WO2010135695A2 (en) | 2009-05-22 | 2010-11-25 | Curna, Inc. | TREATMENT OF TRANSCRIPTION FACTOR E3 (TFE3) and INSULIN RECEPTOR SUBSTRATE 2 (IRS2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TFE3 |
EP2435571B1 (en) | 2009-05-28 | 2016-12-14 | CuRNA, Inc. | Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene |
ES2629339T3 (es) | 2009-06-16 | 2017-08-08 | Curna, Inc. | Tratamiento de enfermedades relacionadas con la paraoxonasa 1 (pon1) por inhibición de transcrito antisentido natural a pon1 |
KR101801404B1 (ko) | 2009-06-16 | 2017-12-20 | 큐알엔에이, 인크. | 콜라겐 유전자에 대한 천연 안티센스 전사체의 억제에 의한 콜라겐 유전자 관련된 질환의 치료 |
CN102656270B (zh) | 2009-06-19 | 2015-05-13 | 巴斯夫植物科学有限公司 | 具有增强的产量相关性状的植物和用于产生该植物的方法 |
CA2765889A1 (en) | 2009-06-24 | 2010-12-29 | Opko Curna, Llc | Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2 |
KR101807324B1 (ko) | 2009-06-26 | 2017-12-08 | 큐알엔에이, 인크. | 다운 증후군 유전자에 대한 천연 안티센스 전사체의 억제에 의한 다운 증후군 유전자 관련된 질환의 치료 |
AU2010273756A1 (en) | 2009-06-30 | 2011-11-24 | E. I. Du Pont De Nemours And Company | Plant seeds with altered storage compound levels, related constructs and methods involving genes encoding cytosolic pyrophosphatase |
ES2385451T3 (es) | 2009-07-10 | 2012-07-25 | Freie Universität Berlin | Rock2 y Rock3, dos nuevas variantes de ganancia de función de los receptores de citoquinina AHK2 y AHK3 |
EP2275564A1 (en) | 2009-07-17 | 2011-01-19 | Freie Universität Berlin | Means and method for the production of transgenic plants that are resistant to clubroot |
CA2768331A1 (en) | 2009-07-23 | 2011-01-27 | Basf Plant Science Company Gmbh | Plants with increased yield |
AU2010274146A1 (en) | 2009-07-24 | 2012-02-02 | Pioneer Hi-Bred International, Inc. | The use of dimerization domain component stacks to modulate plant architecture |
WO2011017132A2 (en) * | 2009-07-27 | 2011-02-10 | Purdue Research, Foundation | Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration |
CA2769665A1 (en) | 2009-08-05 | 2011-02-10 | Opko Curna, Llc | Treatment of insulin gene (ins) related diseases by inhibition of natural antisense transcript to an insulin gene (ins) |
WO2011017492A2 (en) | 2009-08-05 | 2011-02-10 | Pioneer Hi-Bred International, Inc. | Novel eto1 genes and use of same for reduced ethylene and improved stress tolerance in plants |
EP2462153B1 (en) | 2009-08-06 | 2015-07-29 | Isis Pharmaceuticals, Inc. | Bicyclic cyclohexose nucleic acid analogs |
GB0914012D0 (en) | 2009-08-11 | 2009-09-16 | Plant Bioscience Ltd | Stress tolerant plants |
ES2542536T3 (es) | 2009-08-19 | 2015-08-06 | Basf Plant Science Company Gmbh | Plantas que tienen rasgos potenciados relacionados con el rendimiento y un procedimiento de producción de las mismas |
CA2770872A1 (en) | 2009-08-20 | 2011-02-24 | Pioneer Hi-Bred International, Inc. | Functional expression of yeast nitrate transporter (ynt1) in maize to improve nitrate uptake |
KR101892760B1 (ko) | 2009-08-25 | 2018-08-28 | 큐알엔에이, 인크. | IQGAP에 대한 천연 안티센스 전사체의 억제에 의한 GTPase 활성화 단백질을 함유하는 IQ 모티프(IQGAP)와 관련된 질환의 치료 |
EP3153584B1 (en) | 2009-08-31 | 2019-10-09 | BASF Plant Science Company GmbH | Regulatory nucleic acid molecules for enhancing seed-specific and/or seed-preferential gene expression in plants |
CN106222166B (zh) | 2009-08-31 | 2020-09-08 | 巴斯夫植物科学有限公司 | 用于在植物中增强种子特异性基因表达而促进增强的多不饱和脂肪酸合成的调节性核酸分子 |
EP3581657B1 (en) | 2009-08-31 | 2022-01-12 | BASF Plant Science Company GmbH | Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
DK2473522T3 (en) | 2009-09-02 | 2016-11-28 | Genentech Inc | Smoothened MUTANT AND METHODS OF USING THE SAME |
KR101754083B1 (ko) | 2009-09-25 | 2017-07-05 | 바스프 플랜트 사이언스 컴퍼니 게엠베하 | 향상된 수확량 관련 형질을 갖는 식물 및 이의 제조 방법 |
CA2772983A1 (en) | 2009-09-25 | 2011-03-31 | Basf Plant Science Company Gmbh | Plants having enhanced yield-related traits and a method for making the same |
CA2775093A1 (en) | 2009-10-02 | 2011-04-07 | Pioneer Hi-Bred International, Inc. | Down-regulation of acc synthase for improved plant performance |
AU2010309990A1 (en) | 2009-10-22 | 2012-05-24 | Basf Plant Science Company Gmbh | Plants having enhanced yield-related traits and a method for making the same |
RU2539772C2 (ru) | 2009-10-22 | 2015-01-27 | Дженентек, Инк. | Способы и композиции для модуляции гепсином стимулирующего макрофаги белка |
AR078829A1 (es) | 2009-10-30 | 2011-12-07 | Du Pont | Plantas y semillas con niveles alterados de compuesto de almacenamiento, construcciones relacionadas y metodos relacionados con genes que codifican proteinas similares a las aldolasas bacterianas de la clase ii del acido 2,4- dihidroxi-hept-2-eno-1,7-dioico |
AU2010313154B2 (en) | 2009-10-30 | 2016-05-12 | Northwestern University | Templated nanoconjugates |
EP2499251A1 (en) | 2009-11-13 | 2012-09-19 | BASF Plant Science Company GmbH | Plants having enhanced yield-related traits and a method for making the same |
CN102712928B (zh) | 2009-11-13 | 2017-08-04 | 萨雷普塔治疗公司 | 反义抗病毒化合物及治疗流感病毒感染的方法 |
WO2011061656A1 (en) | 2009-11-17 | 2011-05-26 | Basf Plant Science Company Gmbh | Plants with increased yield |
CN102666837A (zh) | 2009-11-23 | 2012-09-12 | 纽塞利斯公司 | 使用酵母产生角鲨烯的方法和组合物 |
PE20121584A1 (es) | 2009-11-30 | 2012-11-29 | Genentech Inc | Composiciones y metodos para el diagnostico y el tratamiento de tumores |
ES2661813T3 (es) | 2009-12-16 | 2018-04-04 | Curna, Inc. | Tratamiento de enfermedades relacionadas con la peptidasa del factor de transcripción de membrana, sitio 1 (mbtps1) mediante inhibición del transcrito antisentido natural al gen mbtps1 |
EP2515947B1 (en) | 2009-12-23 | 2021-10-06 | CuRNA, Inc. | Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2 |
WO2011079261A2 (en) | 2009-12-23 | 2011-06-30 | Curna, Inc. | Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf |
WO2011090690A1 (en) | 2009-12-28 | 2011-07-28 | Pioneer Hi-Bred International, Inc. | Sorghum fertility restorer genotypes and methods of marker-assisted selection |
JP5982288B2 (ja) | 2009-12-29 | 2016-08-31 | カッパーアールエヌエー,インコーポレイテッド | 腫瘍タンパク質63(p63)に対する天然アンチセンス転写物の阻害による腫瘍タンパク質63関連疾患の治療 |
RU2615450C2 (ru) | 2009-12-29 | 2017-04-04 | Курна, Инк. | Лечение заболеваний, связанных с ядерным респираторным фактором 1(nrf1), путем ингибирования природного антисмыслового транскрипта к nrf1 |
CA2786001A1 (en) | 2009-12-31 | 2011-07-07 | Pioneer Hi-Bred International, Inc. | Engineering plant resistance to diseases caused by pathogens |
DK2521784T3 (en) | 2010-01-04 | 2018-03-12 | Curna Inc | TREATMENT OF INTERFERON REGULATORY FACTOR 8- (IRF8) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENCE TRANSCRIPT TO IRF8 |
EP2521788A1 (en) | 2010-01-06 | 2012-11-14 | Pioneer Hi-Bred International Inc. | Identification of diurnal rhythms in photosynthetic and non-photosynthetic tissues from zea mays and use in improving crop plants |
JP5963680B2 (ja) | 2010-01-06 | 2016-08-03 | カッパーアールエヌエー,インコーポレイテッド | 膵臓発生遺伝子に対する天然アンチセンス転写物の阻害による膵臓発生遺伝子疾患の治療 |
US8779118B2 (en) | 2010-01-11 | 2014-07-15 | Isis Pharmaceuticals, Inc. | Base modified bicyclic nucleosides and oligomeric compounds prepared therefrom |
WO2011085347A2 (en) | 2010-01-11 | 2011-07-14 | Opko Curna, Llc | Treatment of sex hormone binding globulin (shbg) related diseases by inhibition of natural antisense transcript to shbg |
WO2011091244A1 (en) | 2010-01-21 | 2011-07-28 | NellOne Therapeutics, Inc. | Methods to treat or prevent a skin condition using a nell1 peptide |
ES2671877T3 (es) | 2010-01-25 | 2018-06-11 | Curna, Inc. | Tratamiento de enfermedades relacionadas con la RNASA (H1) mediante inhibición del transcrito antisentido natural a RNASA H1 |
US9611485B2 (en) | 2010-01-26 | 2017-04-04 | Pioneer Hi-Bred International, Inc. | Polynucleotide and polypeptide sequences associated with herbicide tolerance |
CN102844435B (zh) | 2010-02-22 | 2017-05-10 | 库尔纳公司 | 通过抑制吡咯啉‑5‑羧酸还原酶1(pycr1)的天然反义转录物而治疗pycr1相关疾病 |
WO2011105900A2 (en) | 2010-02-23 | 2011-09-01 | Academisch Ziekenhuis Bij De Universiteit Van Amsterdam | Antagonists of complement component 8-alpha (c8-alpha) and uses thereof |
WO2011105901A2 (en) | 2010-02-23 | 2011-09-01 | Academisch Ziekenhuis Bij De Universiteit Van Amsterdam | Antagonists of complement component 9 (c9) and uses thereof |
KR20130004579A (ko) | 2010-02-23 | 2013-01-11 | 제넨테크, 인크. | 종양의 진단 및 치료를 위한 조성물 및 방법 |
WO2011105902A2 (en) | 2010-02-23 | 2011-09-01 | Academisch Ziekenhuis Bij De Universiteit Van Amsterdam | Antagonists of complement component 8-beta (c8-beta) and uses thereof |
MX2012009524A (es) | 2010-02-24 | 2012-09-12 | Basf Plant Science Co Gmbh | Plantas que tienen mejores rasgos relacionados con el rendimiento y un metodo para producirlas. |
AU2011219927A1 (en) | 2010-02-24 | 2012-08-23 | Basf Plant Science Company Gmbh | Plants having enhanced yield-related traits and a method for making the same |
EP2361927A1 (en) | 2010-02-26 | 2011-08-31 | BASF Plant Science Company GmbH | Plants having enhanced yield-related traits and a method for making the same |
EP2361985A1 (en) | 2010-02-26 | 2011-08-31 | BASF Plant Science Company GmbH | Plants having enhanced yield-related traits and a method for making the same |
EP2860254A1 (en) | 2010-03-03 | 2015-04-15 | E. I. du Pont de Nemours and Company | Plant seeds with altered storage compound levels, related constructs and methods involving genes encoding oxidoreductase motif polypeptides |
GB201003702D0 (en) | 2010-03-05 | 2010-04-21 | Univ Warwick | Molecular engineering of a floral inducer for crop improvement |
US9068185B2 (en) | 2010-03-12 | 2015-06-30 | Sarepta Therapeutics, Inc. | Antisense modulation of nuclear hormone receptors |
EP2544703A4 (en) | 2010-03-12 | 2013-09-18 | Brigham & Womens Hospital | METHODS OF TREATING VASCULAR INFLAMMATORY DISORDERS |
US9193752B2 (en) | 2010-03-17 | 2015-11-24 | Isis Pharmaceuticals, Inc. | 5′-substituted bicyclic nucleosides and oligomeric compounds prepared therefrom |
AU2011228733A1 (en) | 2010-03-18 | 2012-11-08 | Basf Plant Science Company Gmbh | Plants having enhanced yield-related traits and method for making the same |
AU2011228707A1 (en) | 2010-03-18 | 2012-09-27 | Basf Plant Science Company Gmbh | Plants having enhanced yield-related traits and method for making the same |
EA201290936A1 (ru) | 2010-03-19 | 2013-05-30 | Басф Плант Сайенс Компани Гмбх | Растения с улучшенными характеристиками урожайности и способ их получения |
BR112012023503A2 (pt) | 2010-03-19 | 2015-09-01 | Basf Plant Science Co Gmbh | Método para aumentar o rendimento em plantas em relação a plantas de controle, planta, construção, uso de uma construção, métodos para a produção de uma planta transgênica e de um produto, partes colhíveis de uma planta, produtos derivados de uma planta e uso de um ácido nucleico |
EP2371845A1 (en) | 2010-03-22 | 2011-10-05 | BASF Plant Science Company GmbH | Plants having enhanced yield-related traits and a method for making the same |
EP2556160A4 (en) | 2010-04-09 | 2013-08-21 | Curna Inc | TREATMENT OF ILLNESSES ASSOCIATED WITH FIBROBLASTIC GROWTH FACTOR 21 (FGF21) BY INHIBITION OF THE NATURAL ANTISENSE TRANSCRIPT AGAINST FGF21 |
EP2385129A1 (en) | 2010-05-03 | 2011-11-09 | BASF Plant Science Company GmbH | Enhanced methods for gene regulation in plants |
WO2011139714A2 (en) | 2010-04-26 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase |
CN103096911B (zh) | 2010-04-27 | 2018-05-29 | Atyr 医药公司 | 与异亮氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现 |
EP2625186B1 (en) | 2010-04-28 | 2016-07-27 | Ionis Pharmaceuticals, Inc. | 5' modified nucleosides and oligomeric compounds prepared therefrom |
CN103154014B (zh) | 2010-04-28 | 2015-03-25 | Isis制药公司 | 修饰核苷、其类似物以及由它们制备的寡聚化合物 |
WO2011139853A2 (en) | 2010-04-28 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases |
WO2011150279A2 (en) | 2010-05-27 | 2011-12-01 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases |
AU2011248457B2 (en) | 2010-04-29 | 2017-02-16 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl tRNA synthetases |
ES2625689T3 (es) | 2010-04-29 | 2017-07-20 | Ionis Pharmaceuticals, Inc. | Modulación de la expresión de transtiretina |
CN103097523B (zh) | 2010-04-29 | 2016-09-28 | Atyr医药公司 | 与天冬酰胺酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现 |
CN107090045A (zh) | 2010-05-03 | 2017-08-25 | 霍夫曼-拉罗奇有限公司 | 用于肿瘤诊断和治疗的组合物和方法 |
WO2011139387A1 (en) | 2010-05-03 | 2011-11-10 | Opko Curna, Llc | Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt) |
US8961961B2 (en) | 2010-05-03 | 2015-02-24 | a Tyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of arginyl-tRNA synthetases |
CN105820252B (zh) | 2010-05-03 | 2020-07-21 | Atyr 医药公司 | 与苯丙氨酰-α-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现 |
US8981045B2 (en) | 2010-05-03 | 2015-03-17 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-tRNA synthetases |
CA2798139C (en) | 2010-05-04 | 2019-09-24 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex |
US20130053243A1 (en) | 2010-05-04 | 2013-02-28 | Basf Se | Plants having increased tolerance to herbicides |
EA201291178A1 (ru) | 2010-05-06 | 2013-04-30 | Пайонир Хай-Бред Интернэшнл, Инк. | Ген и белок acc-синтазы 3 маиса и их применения |
GB201007834D0 (en) | 2010-05-11 | 2010-06-23 | Vib Vzw | Growth promoting fusion proteins |
US9457079B2 (en) | 2010-05-12 | 2016-10-04 | The Trustees Of Columbia University In The City Of New York | Methods for producing enteroendocrine cells that make and secrete insulin |
ES2816898T3 (es) | 2010-05-13 | 2021-04-06 | Sarepta Therapeutics Inc | Compuestos que modulan la actividad de señalización de las interleucinas 17 y 23 |
TWI586356B (zh) | 2010-05-14 | 2017-06-11 | 可娜公司 | 藉由抑制par4天然反股轉錄本治療par4相關疾病 |
CN103200953B (zh) | 2010-05-14 | 2017-02-15 | Atyr 医药公司 | 与苯丙氨酰‑β‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现 |
AU2011256366C1 (en) | 2010-05-17 | 2017-06-15 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases |
KR20180053419A (ko) | 2010-05-26 | 2018-05-21 | 큐알엔에이, 인크. | 무조(無調)의 동소체 1 (atoh1)에 대한 자연 안티센스 전사체의 저해에 의한 atoh1 관련된 질환의 치료 |
US8957200B2 (en) | 2010-06-07 | 2015-02-17 | Isis Pharmaceuticals, Inc. | Bicyclic nucleosides and oligomeric compounds prepared therefrom |
US8846637B2 (en) | 2010-06-08 | 2014-09-30 | Isis Pharmaceuticals, Inc. | Substituted 2′-amino and 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom |
JP2013532152A (ja) | 2010-06-15 | 2013-08-15 | メドジェニクス・メディカル・イスラエル・リミテッド | 長期持続性の医薬製剤 |
MX2012015045A (es) | 2010-06-24 | 2013-01-29 | Basf Plant Science Co Gmbh | Plantas que tienen mejores rasgos relacionados con el rendimiento y un metodo para producirlas. |
WO2011161620A1 (en) | 2010-06-25 | 2011-12-29 | Basf Plant Science Company Gmbh | Plants with enhanced yield-related traits and producing method thereof |
AU2011271497A1 (en) | 2010-07-01 | 2013-01-10 | E. I. Du Pont De Nemours And Company | Plant seeds with altered storage compound levels, related constructs and methods involving genes encoding PAE and PAE-like polypeptides |
EA201390077A1 (ru) | 2010-07-08 | 2013-06-28 | Байер Кропсайенс Нв | Белок-переносчик глюкозинолатов и его применения |
AU2011289831C1 (en) | 2010-07-12 | 2017-06-15 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases |
WO2012009402A2 (en) | 2010-07-14 | 2012-01-19 | Opko Curna Llc | Treatment of discs large homolog (dlg) related diseases by inhibition of natural antisense transcript to dlg |
DE112011102378T5 (de) | 2010-07-16 | 2013-04-18 | Basf Plant Science Company Gmbh | Pflanzen mit gesteigerten ertragsbezogenen Eigenschaften und Verfahren zur Herstellung derselben |
UA112969C2 (uk) | 2010-08-03 | 2016-11-25 | Сібас Юс Ллс | Рослина, стійка до одного або більше ррх-інгібуючих гербіцидів, яка містить мутантний ген протопорфіриноген ix оксидази (ррх) |
US20120122223A1 (en) | 2010-08-03 | 2012-05-17 | Cibus Us Llc | Mutated protoporphyrinogen ix oxidase (ppx) genes |
US9187762B2 (en) | 2010-08-13 | 2015-11-17 | Pioneer Hi-Bred International, Inc. | Compositions and methods comprising sequences having hydroxyphenylpyruvate dioxygenase (HPPD) activity |
CN103154254A (zh) | 2010-08-24 | 2013-06-12 | 巴斯夫植物科学有限公司 | 具有增强的产量相关性状的植物和产生该植物的方法 |
CN103108650A (zh) | 2010-08-25 | 2013-05-15 | Atyr医药公司 | 与酪氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现 |
EP2426204A1 (en) | 2010-09-02 | 2012-03-07 | Ludwig-Maximilians-Universität München | Spontaneous nodule organogenesis in plants |
WO2012028673A1 (en) | 2010-09-02 | 2012-03-08 | Ludwig-Maximilians-Universitaet Muenchen | Spontaneous organogenesis in plants |
AU2011312205B2 (en) | 2010-10-05 | 2015-08-13 | Curis, Inc. | Mutant smoothened and methods of using the same |
CA2813901C (en) | 2010-10-06 | 2019-11-12 | Curna, Inc. | Treatment of sialidase 4 (neu4) related diseases by inhibition of natural antisense transcript to neu4 |
US20140031250A1 (en) | 2010-10-07 | 2014-01-30 | David Tsai Ting | Biomarkers of Cancer |
EP2630241B1 (en) | 2010-10-22 | 2018-10-17 | CuRNA, Inc. | Treatment of alpha-l-iduronidase (idua) related diseases by inhibition of natural antisense transcript to idua |
ES2677070T3 (es) | 2010-10-27 | 2018-07-27 | Curna, Inc. | Tratamiento de enfermedades relacionadas con el regulador del desarrollo 1 asociado a interferón (ifrd1) mediante inhibición del transcrito antisentido natural al gen ifrd1 |
MX2013005236A (es) | 2010-11-10 | 2013-06-28 | Basf Plant Science Co Gmbh | Plantas que tienen mejores rasgos relacionados con el rendimiento y un metodo para producirlas. |
EP2638163B1 (en) | 2010-11-12 | 2017-05-17 | The General Hospital Corporation | Polycomb-associated non-coding rnas |
US8609621B2 (en) | 2010-11-15 | 2013-12-17 | E I Du Pont De Nemours And Company | Acid-cleavable linkers exhibiting altered rates of acid hydrolysis |
EP2640853B1 (en) | 2010-11-17 | 2018-12-26 | Ionis Pharmaceuticals, Inc. | Modulation of alpha synuclein expression |
ES2657590T3 (es) | 2010-11-23 | 2018-03-06 | Curna, Inc. | Tratamiento de enfermedades relacionadas con nanog mediante inhibición del transcrito antisentido natural a nanog |
DE112011104038T5 (de) | 2010-12-06 | 2013-09-12 | Basf Plant Science Company Gmbh | Verfahren zur Herstellung synthetischer Promotoren mit definierter Spezifität |
ES2903230T3 (es) | 2010-12-16 | 2022-03-31 | Basf Agro Bv | Plantas que tienen mayor tolerancia a los herbicidas |
PL2655657T3 (pl) | 2010-12-22 | 2019-06-28 | Pioneer Hi-Bred International, Inc. | Loci QTL związane z odpornością polową całej rośliny na Sclerotinię oraz sposoby jej identyfikacji |
US9045749B2 (en) | 2011-01-14 | 2015-06-02 | The General Hospital Corporation | Methods targeting miR-128 for regulating cholesterol/lipid metabolism |
MX2013008086A (es) | 2011-01-20 | 2013-10-03 | Basf Plant Science Co Gmbh | Plantas que tienen mejores rasgos relacionados con el rendimiento y un metodo para producirlas. |
WO2012101599A2 (en) | 2011-01-27 | 2012-08-02 | Ramot At Tel-Aviv University Ltd. | Glycogen synthase kinase-3 inhibitors |
WO2012101601A1 (en) | 2011-01-27 | 2012-08-02 | Ramot At Tel-Aviv University Ltd. | Glycogen synthase kinase-3 inhibitors |
MX347631B (es) | 2011-02-01 | 2017-05-04 | Colorado Wheat Res Foundation Inc | Plantas resistentes a herbicida en acetil co-enzima a carboxilasa. |
US20130338178A1 (en) | 2011-02-02 | 2013-12-19 | The Trustees Of Princeton University | Sirtuin modulators as inhibitors of cytomegalovirus |
TWI593416B (zh) | 2011-02-02 | 2017-08-01 | 艾克厘德製藥公司 | 利用針對結締組織生長因子(ctgf)目標之反義化合物治療瘢痕或肥厚性疤痕之方法 |
US9273336B2 (en) | 2011-02-21 | 2016-03-01 | E. I. Du Pont De Nemours And Company | Recombinant host cells having an increase in buoyant density |
AR085394A1 (es) | 2011-02-25 | 2013-09-25 | Univ Nac De La Plata Unlp | Proteasa de plantas |
CA2826859A1 (en) | 2011-02-28 | 2012-09-07 | Basf Plant Science Company Gmbh | Plants having enhanced yield-related traits and producing methods thereof |
WO2012117324A1 (en) | 2011-02-28 | 2012-09-07 | Basf Plant Science Company Gmbh | Plants having enhanced yield-related traits and producing methods thereof |
AU2012222946A1 (en) | 2011-03-01 | 2013-09-19 | Basf Plant Science Company Gmbh | Plants having enhanced yield-related traits and producing methods thereof |
US9890200B2 (en) | 2011-04-12 | 2018-02-13 | Moerae Matrix, Inc. | Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition |
ES2711670T3 (es) | 2011-04-12 | 2019-05-06 | Moerae Matrix Inc | Composiciones y métodos para la prevención o tratamiento de la fibrosis pulmonar |
CN103502269A (zh) | 2011-04-29 | 2014-01-08 | 先锋国际良种公司 | 下调同源域-亮氨酸拉链i类同源盒基因以改进植物性能 |
WO2012156760A1 (en) | 2011-05-19 | 2012-11-22 | Consejo Superior De Investigaciones Cientificas | Process for modifying the architecture and improving the yield of crop plants |
WO2012170347A1 (en) | 2011-06-09 | 2012-12-13 | Isis Pharmaceuticals, Inc. | Bicyclic nucleosides and oligomeric compounds prepared therefrom |
RU2620980C2 (ru) | 2011-06-09 | 2017-05-30 | Курна, Инк. | Лечение заболеваний, связанных с фратаксином (fxn), путем ингибирования природного антисмыслового транскрипта fxn |
US20140216118A1 (en) | 2011-06-14 | 2014-08-07 | Synthon Biopharmaceuticals B.V. | Compositions and Methods for Making and Biocontaining Auxotrophic Transgenic Plants |
US20130097734A1 (en) | 2011-07-12 | 2013-04-18 | Two Blades Foundation | Late blight resistance genes |
AU2012284205B2 (en) | 2011-07-15 | 2016-11-17 | Syngenta Participations Ag | Methods of increasing yield and stress tolerance in a plant |
WO2013012643A1 (en) | 2011-07-15 | 2013-01-24 | Syngenta Participations Ag | Polynucleotides encoding trehalose-6-phosphate phosphatase and methods of use thereof |
EP3112465A3 (en) | 2011-08-01 | 2017-04-12 | BASF Plant Science Company GmbH | Method for identification and isolation of terminator sequences causing enhanced transcription |
JP6129844B2 (ja) | 2011-09-14 | 2017-05-17 | ラナ セラピューティクス インコーポレイテッド | 多量体オリゴヌクレオチド化合物 |
CA2847698C (en) | 2011-09-14 | 2020-09-01 | Northwestern University | Nanoconjugates able to cross the blood-brain barrier |
BR112014008925A2 (pt) | 2011-10-11 | 2020-10-27 | The Brigham And Women's Hospital, Inc. | micro rnas em distúrbios de neurodegenerativos |
CN103906835A (zh) | 2011-10-25 | 2014-07-02 | 先锋国际良种公司 | 改变植物细胞壁组成以改善生物燃料生产和青贮饲料可消化性的方法 |
US20150159166A1 (en) | 2011-10-31 | 2015-06-11 | Pioneer Hi Bred International Inc | Plant drought tolerance and nitrogen use efficiency by reducing plant sensitivity to ethylene |
DK2790736T3 (en) | 2011-12-12 | 2018-05-07 | Oncoimmunin Inc | In vivo delivery of oligonucleotides |
CA2863795A1 (en) | 2012-02-13 | 2013-08-22 | Gamida-Cell Ltd. | Culturing of mesenchymal stem cells |
US9452218B2 (en) | 2012-03-09 | 2016-09-27 | Purdue Research Foundation | Compositions and methods for delivery of kinase inhibiting peptides |
CN104703998B (zh) | 2012-03-13 | 2020-08-21 | 先锋国际良种公司 | 植物中雄性育性的遗传减少 |
WO2013138309A1 (en) | 2012-03-13 | 2013-09-19 | Pioneer Hi-Bred International, Inc. | Genetic reduction of male fertility in plants |
US20150031750A1 (en) | 2012-03-15 | 2015-01-29 | The Scripps Research Institute | Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf |
US9610362B2 (en) | 2012-03-16 | 2017-04-04 | Valerion Therapeutics, Llc | Antisense conjugates for decreasing expression of DMPK |
EP2850092B1 (en) | 2012-04-09 | 2017-03-01 | Ionis Pharmaceuticals, Inc. | Tricyclic nucleic acid analogs |
WO2013154799A1 (en) | 2012-04-09 | 2013-10-17 | Isis Pharmaceuticals, Inc. | Tricyclic nucleosides and oligomeric compounds prepared therefrom |
CN104704122A (zh) | 2012-04-20 | 2015-06-10 | 艾珀特玛治疗公司 | 产热的miRNA调节剂 |
US10059941B2 (en) | 2012-05-16 | 2018-08-28 | Translate Bio Ma, Inc. | Compositions and methods for modulating SMN gene family expression |
CA2873809A1 (en) | 2012-05-16 | 2013-11-21 | Rana Therapeutics, Inc. | Compositions and methods for modulating gene expression |
US10045499B2 (en) | 2012-05-24 | 2018-08-14 | Iowa State University Research Foundation, Inc. | Arabidopsis nonhost resistance gene(s) and use thereof to engineer disease resistant plants |
WO2013184209A1 (en) | 2012-06-04 | 2013-12-12 | Ludwig Institute For Cancer Research Ltd. | Mif for use in methods of treating subjects with a neurodegenerative disorder |
AR091489A1 (es) | 2012-06-19 | 2015-02-11 | Basf Se | Plantas que tienen una mayor tolerancia a herbicidas inhibidores de la protoporfirinogeno oxidasa (ppo) |
EP2677035A1 (en) | 2012-06-22 | 2013-12-25 | BASF Plant Science Company GmbH | Plants having enhanced yield-related traits and a method for making the same |
US9567569B2 (en) | 2012-07-23 | 2017-02-14 | Gamida Cell Ltd. | Methods of culturing and expanding mesenchymal stem cells |
US9175266B2 (en) | 2012-07-23 | 2015-11-03 | Gamida Cell Ltd. | Enhancement of natural killer (NK) cell proliferation and activity |
US20150216892A1 (en) | 2012-08-03 | 2015-08-06 | Aptamir Therapeutics, Inc. | Cell-specific delivery of mirna modulators for the treatment of obesity and related disorders |
EP2885312A4 (en) | 2012-08-15 | 2016-01-20 | Isis Pharmaceuticals Inc | PROCESS FOR THE PREPARATION OF OLIGOMERIC COMPOUNDS USING MODIFIED STREAMING PROTOCOLS |
WO2014027021A1 (en) | 2012-08-16 | 2014-02-20 | Vib Vzw | Means and methods for altering the lignin pathway in plants |
WO2014037735A1 (en) | 2012-09-10 | 2014-03-13 | University Of Leicester | Atsp1, an e3 ubiquitin ligase, and its use |
US9029335B2 (en) | 2012-10-16 | 2015-05-12 | Isis Pharmaceuticals, Inc. | Substituted 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom |
AU2013336237A1 (en) | 2012-10-22 | 2015-06-11 | Sabag-Rfa Ltd | A system for delivering therapeutic agents into living cells and cells nuclei |
CN105473720A (zh) | 2012-11-20 | 2016-04-06 | 先锋国际良种公司 | 用于高效摄取和利用尿素以提高作物产量的工程改造植物 |
US20150351390A1 (en) | 2012-12-21 | 2015-12-10 | Pioneer Hi-Bred International, Inc. | Compositions and methods for auxin-analog conjugation |
EP2754715A1 (en) | 2013-01-11 | 2014-07-16 | Consejo Superior De Investigaciones Científicas (CSIC) | Stress tolerant plants |
WO2014118018A1 (en) | 2013-01-29 | 2014-08-07 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing ein2 |
WO2014117988A1 (en) | 2013-01-29 | 2014-08-07 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing hcp7 |
CA2897485A1 (en) | 2013-01-29 | 2014-08-07 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing hcp6 |
WO2014121436A1 (en) | 2013-02-05 | 2014-08-14 | Plant Bioscience Limited | Transgenic plants |
US10465204B2 (en) | 2013-03-08 | 2019-11-05 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing MybTF |
US20160002648A1 (en) | 2013-03-11 | 2016-01-07 | Mei Guo | Genes for improving nutrient uptake and abiotic stress tolerance in plants |
US10329574B2 (en) | 2013-03-12 | 2019-06-25 | E I Du Pont De Nemours And Company | Methods for the identification of variant recognition sites for rare-cutting engineered double-strand-break-inducing agents and compositions and uses thereof |
US9803214B2 (en) | 2013-03-12 | 2017-10-31 | Pioneer Hi-Bred International, Inc. | Breeding pair of wheat plants comprising an MS45 promoter inverted repeat that confers male sterility and a construct that restores fertility |
US20160010101A1 (en) | 2013-03-13 | 2016-01-14 | Pioneer Hi-Bred International, Inc. | Enhanced nitrate uptake and nitrate translocation by over- expressing maize functional low-affinity nitrate transporters in transgenic maize |
WO2014164116A1 (en) | 2013-03-13 | 2014-10-09 | Pioneer Hi-Bred International, Inc. | Functional expression of bacterial major facilitator superfamily (sfm) gene in maize to improve agronomic traits and grain yield |
EP2971003A4 (en) | 2013-03-14 | 2016-11-16 | Cibus Us Llc | MUTED ALLENOXIDE SYNTHASE-2 (AOS2) GENES |
CA2903693A1 (en) | 2013-03-14 | 2014-10-02 | Pioneer Hi-Bred International, Inc. | Maize stress related transcription factor 18 and uses thereof |
US11434494B2 (en) | 2013-03-15 | 2022-09-06 | Cibus Us Llc | Targeted gene modification using oligonucleotide-mediated gene repair |
US20140283216A1 (en) | 2013-03-15 | 2014-09-18 | Pioneer Hi Bred International Inc | Compositions and methods of use of acc oxidase polynucleotides and polypeptides |
WO2014152507A2 (en) | 2013-03-15 | 2014-09-25 | Pioneer Hi-Bred International, Inc. | Modulation of acc deaminase expression |
US9957515B2 (en) | 2013-03-15 | 2018-05-01 | Cibus Us Llc | Methods and compositions for targeted gene modification |
IL307456A (en) | 2013-03-15 | 2023-12-01 | Cibus Us Llc | Methods and compositions for increasing the efficiency of targeted gene modification using oligonucleotide-mediated gene repair |
AU2014234265B2 (en) | 2013-03-21 | 2020-01-30 | Universiteit Gent | Means and methods for the reduction of photorespiration in crops |
EA031393B1 (ru) | 2013-05-01 | 2018-12-28 | Ионис Фармасьютикалз, Инк. | Композиции и способы модулирования экспрессии hbv и ttr |
US20160129089A1 (en) | 2013-06-13 | 2016-05-12 | Antisense Therapeutics Ltd | Combination therapy |
EP2816115A1 (en) | 2013-06-17 | 2014-12-24 | BASF Plant Science Company GmbH | Plants having one or more enhanced yield-related traits and a method for making the same |
EP3013850B1 (en) | 2013-06-24 | 2018-07-25 | Ramot at Tel-Aviv University Ltd. | Glycogen synthase kinase-3 inhibitors |
US11459579B2 (en) | 2013-07-09 | 2022-10-04 | Board Of Trustees Of Michigan State University | Transgenic plants produced with a K-domain, and methods and expression cassettes related thereto |
US10570409B2 (en) | 2013-07-09 | 2020-02-25 | Board Of Trustees Of Michigan State University | Transgenic plants produced with a K-domain, and methods and expression cassettes related thereto |
US11162096B2 (en) | 2013-10-14 | 2021-11-02 | Ionis Pharmaceuticals, Inc | Methods for modulating expression of C9ORF72 antisense transcript |
CA2844640A1 (en) | 2013-12-06 | 2015-06-06 | The University Of British Columbia | Method for treatment of castration-resistant prostate cancer |
EP2896698A1 (en) | 2014-01-17 | 2015-07-22 | BASF Plant Science Company GmbH | Plants having one or more enhanced yield-related traits and a method for making the same |
US20170166920A1 (en) | 2014-01-30 | 2017-06-15 | Two Blades Foundation | Plants with enhanced resistance to phytophthora |
PT3099333T (pt) | 2014-01-31 | 2020-12-24 | Univ Temple | Bag3 como alvo para terapia de insuficiência cardíaca |
CA2937539A1 (en) | 2014-02-04 | 2015-08-13 | Genentech, Inc. | Mutant smoothened and methods of using the same |
KR102450868B1 (ko) | 2014-03-14 | 2022-10-06 | 시버스 유에스 엘엘씨 | 올리고뉴클레오타이드 매개 유전자 보수를 사용한 표적화된 유전자 변형의 효율을 증가시키기 위한 방법 및 조성물 |
WO2015142910A1 (en) | 2014-03-17 | 2015-09-24 | Isis Pharmaceuticals, Inc. | Bicyclic carbocyclic nucleosides and oligomeric compounds prepared therefrom |
US10006027B2 (en) | 2014-03-19 | 2018-06-26 | Ionis Pharmaceuticals, Inc. | Methods for modulating Ataxin 2 expression |
AU2015231130C1 (en) | 2014-03-19 | 2021-12-23 | Ionis Pharmaceuticals, Inc. | Compositions for modulating Ataxin 2 expression |
AU2015240761B2 (en) | 2014-04-01 | 2019-09-12 | Biogen Ma Inc. | Compositions for modulating SOD-1 expression |
WO2015150465A2 (en) | 2014-04-03 | 2015-10-08 | Basf Se | Plants having increased tolerance to herbicides |
US10221416B2 (en) | 2014-04-24 | 2019-03-05 | Ionis Pharmaceuticals, Inc. | Oligomeric compounds comprising alpha-beta-constrained nucleic acid |
BR112016022593B1 (pt) | 2014-05-01 | 2022-04-26 | Ionis Pharmaceuticals, Inc | Compostos oligoméricos, composições que os compreendem, e usos dos mesmos |
WO2015171603A1 (en) | 2014-05-06 | 2015-11-12 | Two Blades Foundation | Methods for producing plants with enhanced resistance to oomycete pathogens |
AU2015269412B2 (en) | 2014-06-04 | 2020-03-12 | Exicure Operating Company | Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications |
HRP20220379T1 (hr) | 2014-06-10 | 2022-05-27 | Erasmus University Medical Center Rotterdam | Antisense oligonukleotidi korisni u liječenju pompeove bolesti |
EP3161159B1 (en) | 2014-06-25 | 2020-08-05 | The General Hospital Corporation | Targeting human satellite ii (hsatii) |
US10487314B2 (en) | 2014-06-26 | 2019-11-26 | The Trustees Of Columbia University In The City Of New York | Inhibition of serotonin expression in gut enteroendocrine cells results in conversion to insulin-positive cells |
EP3166964A1 (en) | 2014-07-08 | 2017-05-17 | Vib Vzw | Means and methods to increase plant yield |
EA039787B1 (ru) | 2014-07-14 | 2022-03-14 | Вашингтон Стейт Юниверсити | Сельскохозяйственное животное с абляцией клеток зародышевой линии и способы его получения |
WO2016033424A1 (en) | 2014-08-29 | 2016-03-03 | Genzyme Corporation | Methods for the prevention and treatment of major adverse cardiovascular events using compounds that modulate apolipoprotein b |
EP3198012B1 (en) | 2014-09-26 | 2019-09-04 | University of Massachusetts | Rna-modulating agents |
EP4268584A3 (en) | 2014-10-06 | 2024-02-21 | Altria Client Services LLC | Genetic control of axillary bud growth in tobacco plants |
KR20170083063A (ko) | 2014-11-17 | 2017-07-17 | 모레 매트릭스 인코포레이티드 | 이상 섬유모세포 증식 및 세포외 기질 침착을 특징으로 하는 질병, 질환, 또는 과정의 예방 또는 치료용 조성물 및 방법 |
WO2016081911A2 (en) | 2014-11-21 | 2016-05-26 | Northwestern University | The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates |
US20170369902A1 (en) | 2014-12-16 | 2017-12-28 | Pioneer Hi-Bred International, Inc. | Restoration of male fertility in wheat |
US9688707B2 (en) | 2014-12-30 | 2017-06-27 | Ionis Pharmaceuticals, Inc. | Bicyclic morpholino compounds and oligomeric compounds prepared therefrom |
US10793855B2 (en) | 2015-01-06 | 2020-10-06 | Ionis Pharmaceuticals, Inc. | Compositions for modulating expression of C9ORF72 antisense transcript |
US10538763B2 (en) | 2015-01-16 | 2020-01-21 | Ionis Pharmaceuticals, Inc. | Compounds and methods for modulation of DUX4 |
JP7040941B2 (ja) | 2015-01-21 | 2022-03-23 | ビーエーエスエフ ソシエタス・ヨーロピア | 除草剤耐性の増加した植物 |
US10485196B2 (en) | 2015-02-03 | 2019-11-26 | The Institute Of Genetics And Developmental Biology Chinese Academy Of Scinces | Rice plants with altered seed phenotype and quality |
WO2016124918A1 (en) | 2015-02-03 | 2016-08-11 | The Institute Of Genetics And Developmental Biology | Plants with increased seed size |
EP3253780A1 (en) | 2015-02-04 | 2017-12-13 | Basf Plant Science Company GmbH | Method of increasing resistance against soybean rust in transgenic plants by increasing the scopoletin content |
GB201501941D0 (en) | 2015-02-05 | 2015-03-25 | British American Tobacco Co | Method |
EP3256487A4 (en) | 2015-02-09 | 2018-07-18 | Duke University | Compositions and methods for epigenome editing |
AR103649A1 (es) | 2015-02-11 | 2017-05-24 | Basf Se | Hidroxifenilpiruvato dioxigenasas resistentes a herbicidas |
GB201502409D0 (en) | 2015-02-13 | 2015-04-01 | British American Tobacco Co | Method |
US11129844B2 (en) | 2015-03-03 | 2021-09-28 | Ionis Pharmaceuticals, Inc. | Compositions and methods for modulating MECP2 expression |
RU2017135072A (ru) | 2015-03-12 | 2019-04-10 | Мори Матрикс, Инк. | Применение пептидсодержащих композиций ингибитора mk2 для лечения немелкоклеточного рака легкого |
EP3271467A1 (en) | 2015-03-18 | 2018-01-24 | Basf Se | Recombinant microorganism for improved production of fine chemicals |
US10961532B2 (en) | 2015-04-07 | 2021-03-30 | The General Hospital Corporation | Methods for reactivating genes on the inactive X chromosome |
WO2016167780A1 (en) | 2015-04-16 | 2016-10-20 | Ionis Pharmaceuticals, Inc. | Compositions for modulating expression of c9orf72 antisense transcript |
CA2985458A1 (en) | 2015-05-09 | 2016-11-17 | Two Blades Foundation | Late blight resistance gene from solanum americanum and methods of use |
CA2988415A1 (en) | 2015-06-04 | 2016-12-08 | Basf Se | Recombinant microorganism for improved production of fine chemicals |
CN107690478B (zh) | 2015-06-12 | 2023-02-03 | 巴斯夫欧洲公司 | 用于改善丙氨酸生产的重组微生物 |
WO2016210241A1 (en) | 2015-06-26 | 2016-12-29 | Beth Israel Deaconess Medical Center, Inc. | Cancer therapy targeting tetraspanin 33 (tspan33) in myeloid derived suppressor cells |
US10590425B2 (en) | 2015-06-29 | 2020-03-17 | Caris Science, Inc. | Therapeutic oligonucleotides |
AU2016298317B2 (en) | 2015-07-28 | 2021-02-18 | Caris Science, Inc. | Targeted oligonucleotides |
US10533175B2 (en) | 2015-09-25 | 2020-01-14 | Ionis Pharmaceuticals, Inc. | Compositions and methods for modulating Ataxin 3 expression |
WO2017062790A1 (en) | 2015-10-09 | 2017-04-13 | Two Blades Foundation | Cold shock protein receptors and methods of use |
ES2938883T3 (es) | 2015-11-05 | 2023-04-17 | Los Angeles Childrens Hospital | Oligo antisentido para su uso en el tratamiento de la leucemia mieloide aguda |
CA3005878A1 (en) | 2015-11-19 | 2017-05-26 | The Brigham And Women's Hospital, Inc. | Lymphocyte antigen cd5-like (cd5l)-interleukin 12b (p40) heterodimers in immunity |
US11058709B1 (en) | 2015-12-04 | 2021-07-13 | Ionis Pharmaceuticals, Inc. | Methods of treating breast cancer |
AU2015416656B2 (en) | 2015-12-07 | 2023-02-23 | Erasmus University Medical Center Rotterdam | Enzymatic replacement therapy and antisense therapy for Pompe disease |
AU2017205462A1 (en) | 2016-01-05 | 2018-06-07 | Ionis Pharmaceuticals, Inc. | Methods for reducing LRRK2 expression |
CN109071625A (zh) | 2016-02-04 | 2018-12-21 | 柯瑞斯公司 | 平滑化突变体和其使用方法 |
CN109072248A (zh) | 2016-02-09 | 2018-12-21 | 希博斯美国有限公司 | 采用寡核苷酸介导的基因修复提高靶向基因修饰的效率的方法和组合物 |
EP3419665A4 (en) | 2016-02-25 | 2019-10-16 | The Brigham and Women's Hospital, Inc. | METHODS OF TREATING FIBROSIS BY TARGETING SMOC2 |
CN117126815A (zh) | 2016-03-11 | 2023-11-28 | 奥驰亚客户服务有限公司 | 用于生产烟杈减少或消除的烟草植物和制品的组合物和方法 |
CA3013799A1 (en) | 2016-03-16 | 2017-09-21 | Ionis Pharmaceuticals, Inc. | Methods of modulating keap1 |
US10577607B2 (en) | 2016-03-16 | 2020-03-03 | Ionis Pharmaceuticals, Inc. | Modulation of DYRK1B expression |
JP2019516393A (ja) | 2016-03-18 | 2019-06-20 | カリス サイエンス インコーポレイテッド | オリゴヌクレオチドプローブおよびその使用 |
EP3436574B1 (en) | 2016-03-30 | 2021-08-25 | Basf Se | Fermentative production of n-butylacrylate using alcohol acyl transferase enzymes |
US10563216B2 (en) | 2016-04-18 | 2020-02-18 | Bloomsburg University of Pennsylvania | Compositions and methods of delivering molecules to plants |
EP4166660A1 (en) | 2016-04-29 | 2023-04-19 | BASF Plant Science Company GmbH | Improved methods for modification of target nucleic acids using fused guide rna - donor molecules |
EP3054014A3 (en) | 2016-05-10 | 2016-11-23 | BASF Plant Science Company GmbH | Use of a fungicide on transgenic plants |
BR112018072473A2 (pt) | 2016-05-20 | 2019-02-19 | Basf Agro Bv | molécula de ácido nucleico, cassete de expressão, célula vegetal, planta, semente, métodos para expressar um ácido nucleico, produzir uma planta, controlar vegetação e cultivar a planta, combinação útil para o controle, processo para preparar uma combinação e uso de uma combinação |
US10897903B2 (en) | 2016-05-24 | 2021-01-26 | Basf Se | Method for controlling PPO resistant weeds |
AU2017271579B2 (en) | 2016-05-25 | 2023-10-19 | Caris Science, Inc. | Oligonucleotide probes and uses thereof |
AU2017269647B2 (en) | 2016-05-26 | 2022-04-14 | Nunhems B.V. | Seedless fruit producing plants |
US11236339B2 (en) | 2016-06-17 | 2022-02-01 | Ionis Pharmaceuticals, Inc. | Modulation of GYS1 expression |
AR108853A1 (es) | 2016-06-22 | 2018-10-03 | Univ North Carolina State | Método para aumentar la eficacia en el uso de nitrógeno y/o la eficiencia en la utilización del nitrógeno en las plantas |
AU2017296195A1 (en) | 2016-07-11 | 2019-01-24 | Translate Bio Ma, Inc. | Nucleic acid conjugates and uses thereof |
WO2018011750A1 (en) | 2016-07-15 | 2018-01-18 | Basf Se | Plants having increased tolerance to herbicides |
WO2018019860A1 (en) | 2016-07-27 | 2018-02-01 | BASF Agro B.V. | Plants having increased tolerance to herbicides |
WO2018019842A1 (en) | 2016-07-29 | 2018-02-01 | Basf Se | Method for controlling ppo resistant weeds |
WO2018019845A1 (en) | 2016-07-29 | 2018-02-01 | Basf Se | Method for controlling ppo resistant weeds |
NL2017294B1 (en) | 2016-08-05 | 2018-02-14 | Univ Erasmus Med Ct Rotterdam | Natural cryptic exon removal by pairs of antisense oligonucleotides. |
US20210368793A1 (en) | 2016-08-05 | 2021-12-02 | Basf Se | Method for Controlling PPO Resistant Weeds |
WO2018024695A1 (en) | 2016-08-05 | 2018-02-08 | Basf Se | Method for controlling ppo resistant weeds |
EP3278667A1 (en) | 2016-08-05 | 2018-02-07 | Basf Se | Method for controlling ppo-inhibitor resistant weeds |
NL2017295B1 (en) | 2016-08-05 | 2018-02-14 | Univ Erasmus Med Ct Rotterdam | Antisense oligomeric compound for Pompe disease |
WO2018029031A1 (en) | 2016-08-09 | 2018-02-15 | Basf Se | Method for controlling ppo resistant weeds |
WO2018029029A1 (en) | 2016-08-09 | 2018-02-15 | Basf Se | Method for controlling ppo resistant weeds |
US11193136B2 (en) | 2016-08-09 | 2021-12-07 | Vib Vzw | Cellulose synthase inhibitors and mutant plants |
CA3032223A1 (en) | 2016-08-09 | 2018-02-15 | Basf Se | Method for controlling ppo resistant weeds |
EP3281525A1 (en) | 2016-08-09 | 2018-02-14 | Basf Se | Method for controlling ppo resistant weeds |
EP3281523A1 (en) | 2016-08-09 | 2018-02-14 | Basf Se | Method for controlling ppo resistant weeds |
EP3281524A1 (en) | 2016-08-09 | 2018-02-14 | Basf Se | Method for controlling ppo resistant weeds |
KR20190065341A (ko) | 2016-10-06 | 2019-06-11 | 아이오니스 파마수티컬즈, 인코포레이티드 | 올리고머 화합물들의 접합 방법 |
US10647989B2 (en) | 2016-10-07 | 2020-05-12 | Altria Client Services Llc | Composition and methods for producing tobacco plants and products having reduced tobacco-specific nitrosamines (TSNAs) |
CA3037046A1 (en) | 2016-10-31 | 2018-05-03 | University Of Massachusetts | Targeting microrna-101-3p in cancer therapy |
JOP20190104A1 (ar) | 2016-11-10 | 2019-05-07 | Ionis Pharmaceuticals Inc | مركبات وطرق لتقليل التعبير عن atxn3 |
EP3548620A4 (en) | 2016-12-02 | 2020-07-22 | Cold Spring Harbor Laboratory | MODULATION OF THE EXPRESSION OF LNC05 |
WO2018112356A1 (en) | 2016-12-16 | 2018-06-21 | Two Blades Foundation | Late blight resistance genes and methods of use |
EA201991300A1 (ru) | 2016-12-20 | 2019-12-30 | Басф Агро Б.В. | Растения, обладающие повышенной толерантностью к гербицидам |
KR20190098246A (ko) | 2016-12-27 | 2019-08-21 | 인바이오스 엔.브이. | 시알일화 화합물의 인 비보 합성 |
WO2018140214A1 (en) | 2017-01-24 | 2018-08-02 | Pioneer Hi-Bred International, Inc. | Nematicidal protein from pseudomonas |
CN110573623A (zh) | 2017-02-09 | 2019-12-13 | 福建农林大学 | 用于提高植物产量的磷酸盐转运蛋白的表达 |
WO2018165564A1 (en) | 2017-03-09 | 2018-09-13 | Ionis Pharmaceuticals, Inc. | Morpholino modified oligomeric compounds |
WO2018195338A1 (en) | 2017-04-20 | 2018-10-25 | Atyr Pharma, Inc. | Compositions and methods for treating lung inflammation |
US20200384115A1 (en) | 2017-04-21 | 2020-12-10 | The Broad Institute , Inc. | Targeted delivery to beta cells |
US11445692B2 (en) | 2017-05-15 | 2022-09-20 | Equi-Nom Ltd. | Quantitative trait loci (QTL) associated with shatter resistant capsules in sesame and uses thereof |
WO2019023587A1 (en) | 2017-07-28 | 2019-01-31 | Two Blades Foundation | POTYVIRUS RESISTANCE GENES AND METHODS OF USE |
US11197884B2 (en) | 2017-08-18 | 2021-12-14 | Ionis Pharmaceuticals, Inc. | Modulation of the notch signaling pathway for treatment of respiratory disorders |
WO2019051173A1 (en) | 2017-09-08 | 2019-03-14 | Ionis Pharmaceuticals, Inc. | MODULATORS OF SMAD7 EXPRESSION |
CN111108205A (zh) | 2017-09-11 | 2020-05-05 | 奥驰亚客户服务有限公司 | 用于生产烟杈减少或消除的烟草植物和制品的组合物和方法 |
TWI809004B (zh) | 2017-11-09 | 2023-07-21 | 美商Ionis製藥公司 | 用於降低snca表現之化合物及方法 |
WO2019108619A1 (en) | 2017-11-28 | 2019-06-06 | Two Blades Foundation | Methods and compositions for enhancing the disease resistance of plants |
IL274683B (en) | 2017-11-29 | 2022-09-01 | Basf Se | Plants with increased resistance to herbicides |
WO2019125804A1 (en) | 2017-12-20 | 2019-06-27 | Basf Se | Nucleases and methods for making and using them |
WO2019126641A2 (en) | 2017-12-21 | 2019-06-27 | Ionis Pharmaceuticals, Inc. | Modulation of frataxin expression |
US11034969B2 (en) | 2017-12-22 | 2021-06-15 | Altria Client Services Llc | Plant comprising recombinant polynucleotides encoding a pigment regulatory transcription factor with a tissue-preferred promoter |
CN107868123B (zh) | 2017-12-25 | 2020-05-12 | 中国农业科学院作物科学研究所 | 一种同时提高植物产量和抗性的基因及其应用 |
EP3737766A4 (en) | 2018-01-09 | 2021-11-24 | Cibus US LLC | BREAK-PROOF GENES AND MUTATIONS |
EP3737226A1 (en) | 2018-01-12 | 2020-11-18 | Two Blades Foundation | Stem rust resistance genes and methods of use |
CN111902537A (zh) | 2018-01-15 | 2020-11-06 | Ionis制药公司 | Dnm2表达的调节剂 |
CN111601893A (zh) | 2018-01-17 | 2020-08-28 | 巴斯夫欧洲公司 | 具有增加的除草剂耐受性的植物 |
AU2019221800A1 (en) | 2018-02-14 | 2020-08-06 | Institute Of Genetics And Developmental Biology Chinese Academy Of Sciences | Methods of increasing nutrient use efficiency |
WO2019169243A1 (en) | 2018-03-02 | 2019-09-06 | Ionis Pharmaceuticals, Inc. | Compounds and methods for the modulation of amyloid-beta precursor protein |
BR112020016001A2 (pt) | 2018-03-02 | 2020-12-15 | Ionis Pharmaceuticals, Inc. | Moduladores de expressão irf4 |
WO2019183440A1 (en) | 2018-03-22 | 2019-09-26 | Ionis Pharmaceuticals, Inc. | Methods for modulating fmr1 expression |
CA3095545A1 (en) | 2018-03-30 | 2019-10-03 | Rheinische Friedrich-Wilhelms-Universitat Bonn | Aptamers for targeted activaton of t cell-mediated immunity |
EP3773017B1 (en) | 2018-04-03 | 2022-06-08 | Altria Client Services LLC | Composition and methods for producing tobacco plants and products having increased phenylalanine and reduced tobacco-specific nitrosamines (tsnas) |
CA3096274A1 (en) | 2018-04-06 | 2019-10-10 | Children's Medical Center Corporation | Compositions and methods for somatic cell reprogramming and modulating imprinting |
CN112041440A (zh) | 2018-04-11 | 2020-12-04 | Ionis制药公司 | Ezh2表达的调节剂 |
CN112368375A (zh) | 2018-04-26 | 2021-02-12 | 巴斯夫欧洲公司 | 脂肪酶 |
EP3788145A1 (en) | 2018-05-03 | 2021-03-10 | Basf Se | Amylase enzymes |
CU20200082A7 (es) | 2018-05-09 | 2021-06-08 | Ionis Pharmaceuticals Inc | Compuestos y métodos para la reducción de la expresión de fxi |
SG11202010215TA (en) | 2018-05-09 | 2020-11-27 | Ionis Pharmaceuticals Inc | Compounds and methods for reducing atxn3 expression |
WO2019219933A1 (en) | 2018-05-17 | 2019-11-21 | Vib Vzw | An engineered combinatorial module of transcription factors to boost production of monoterpenoid indole alkaloids |
CA3103429A1 (en) | 2018-06-14 | 2019-12-19 | Don W. Cleveland | Compounds and methods for increasing stmn2 expression |
US11291176B2 (en) | 2018-06-15 | 2022-04-05 | Nunhems B.V. | Seedless watermelon plants comprising modifications in an ABC transporter gene |
WO2020006267A1 (en) | 2018-06-27 | 2020-01-02 | Ionis Pharmaceuticals, Inc. | Compounds and methods for reducing lrrk2 expression |
WO2020010059A1 (en) | 2018-07-02 | 2020-01-09 | Aptamir Therapeutics, Inc. | Targeted delivery of therapeutic agents to human adipocytes |
AR115847A1 (es) | 2018-07-25 | 2021-03-03 | Ionis Pharmaceuticals Inc | Compuestos y métodos para reducir la expresión de la atxn2 |
EP3843845A4 (en) | 2018-08-29 | 2022-05-11 | University Of Massachusetts | INHIBITION OF PROTEIN KINASE FOR THE TREATMENT OF FRIEDREICH'S ATAXIA |
CA3110656A1 (en) | 2018-09-07 | 2020-03-12 | Basf Plant Science Company Gmbh | Improved method for the production of high levels of pufa in plants |
AU2019334672A1 (en) | 2018-09-07 | 2021-03-25 | Basf Plant Science Company Gmbh | Improved method for the production of high levels of PUFA in plants |
US20230183728A1 (en) | 2018-09-07 | 2023-06-15 | Basf Plant Science Company Gmbh | Improved method for the production of high levels of pufa in plants |
US20210340518A1 (en) | 2018-10-18 | 2021-11-04 | Basf Se | Method for the production of acrylic acid or salts thereof |
TW202028222A (zh) | 2018-11-14 | 2020-08-01 | 美商Ionis製藥公司 | Foxp3表現之調節劑 |
AU2019380940A1 (en) | 2018-11-15 | 2021-06-03 | Ionis Pharmaceuticals, Inc. | Modulators of IRF5 expression |
WO2020127975A1 (en) | 2018-12-20 | 2020-06-25 | Basf Plant Science Company Gmbh | Native delivery of biomolecules into plant cells using ionic complexes with cell-penetrating peptides |
WO2020152104A2 (en) | 2019-01-22 | 2020-07-30 | Basf Se | Method for production of 4-cyano benzoic acid or salts thereof |
CN113660857A (zh) | 2019-01-24 | 2021-11-16 | 奥驰亚客户服务有限公司 | 包含降低的烟碱和降低的烟草特异性亚硝胺的烟草植物 |
KR20210122809A (ko) | 2019-01-31 | 2021-10-12 | 아이오니스 파마수티컬즈, 인코포레이티드 | Yap1 발현의 조절인자 |
WO2020171889A1 (en) | 2019-02-19 | 2020-08-27 | University Of Rochester | Blocking lipid accumulation or inflammation in thyroid eye disease |
GB201902253D0 (en) | 2019-02-19 | 2019-04-03 | Univ Court Univ Of Glasgow | Methods for optogenetic manipulation of stomatal function |
BR112021015323A2 (pt) | 2019-02-27 | 2021-10-05 | Ionis Pharmaceuticals, Inc. | Moduladores de expressão de malat1 |
WO2020185737A1 (en) | 2019-03-11 | 2020-09-17 | Basf Se | Amylases and methods for making and using them |
WO2020183191A1 (en) | 2019-03-14 | 2020-09-17 | Rothamsted Research Limited | Genetically modified plants with enhanced drought tolerance |
WO2020193535A2 (en) | 2019-03-25 | 2020-10-01 | Basf Se | Amylase enzymes |
US20220170001A1 (en) | 2019-03-25 | 2022-06-02 | Basf Se | Amylase Enzymes |
WO2020193532A1 (en) | 2019-03-25 | 2020-10-01 | Basf Se | Cleaning composition having amylase enzymes |
WO2020205463A1 (en) | 2019-03-29 | 2020-10-08 | Ionis Pharmaceuticals, Inc. | Compounds and methods for modulating ube3a-ats |
CN113825838A (zh) | 2019-05-10 | 2021-12-21 | 巴斯夫欧洲公司 | 增强植物中基因表达的调节性核酸分子 |
KR20220029579A (ko) | 2019-06-27 | 2022-03-08 | 바스프 플랜트 사이언스 컴퍼니 게엠베하 | 진균 포자의 형질전환 방법 |
BR112021026248A2 (pt) | 2019-06-27 | 2022-03-03 | Two Blades Found | Molécula de ácido nucleico isolada que codifica uma proteína atrlp23 engenheirada, proteína atrlp23 engenheirada, cassete de expressão, vetor, célula hospedeira, planta ou célula vegetal, métodos para fazer uma proteína atrlp23 engenheirada, para fazer uma molécula de ácido nucleico que codifica uma proteína atrlp23 engenheirada e para intensificar a resistência de uma planta |
US20210071193A1 (en) | 2019-07-12 | 2021-03-11 | The Regents Of The University Of California | Plants with enhanced resistance to bacterial pathogens |
EP3956450A4 (en) | 2019-07-26 | 2022-11-16 | Ionis Pharmaceuticals, Inc. | COMPOUNDS AND METHODS FOR MODULATION OF GFAP |
EP4013767A4 (en) | 2019-08-15 | 2023-10-25 | Ionis Pharmaceuticals, Inc. | COMPOUND-MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF |
BR112022000573A2 (pt) | 2019-08-22 | 2022-03-15 | Basf Se | Polipeptídeo isolado, sintético ou recombinante com atividade alfa-amilase, ácido nucleico isolado, sintético ou recombinante, construto de ácido nucleico, vetor de expressão, célula hospedeira, composição, método para produzir polipeptídeo isolado, sintético ou recombinante, método para preparar uma massa ou um produto de panificação, e, métodos para usar o polipeptídeo isolado, sintético ou recombinante e um domínio c de uma primeira amilase |
CN114729382A (zh) | 2019-09-12 | 2022-07-08 | 巴斯夫欧洲公司 | 增强植物中基因表达的调节性核酸分子 |
WO2021058691A1 (en) | 2019-09-26 | 2021-04-01 | Basf Se | Method for the production of beta-alanine or salts thereof |
WO2021069387A1 (en) | 2019-10-07 | 2021-04-15 | Basf Se | Regulatory nucleic acid molecules for enhancing gene expression in plants |
US20230148071A1 (en) | 2019-12-03 | 2023-05-11 | Basf Se | Regulatory nucleic acid molecules for enhancing gene expression in plants |
AU2020408995A1 (en) | 2019-12-16 | 2022-06-23 | BASF Agricultural Solutions Seed US LLC | Codon-optimized Cas9 endonuclease encoding polynucleotide |
KR20220116173A (ko) | 2019-12-16 | 2022-08-22 | 바스프 아그리컬쳐럴 솔루션즈 시드 유에스 엘엘씨 | 밀의 게놈에의 dna 또는 돌연변이의 정확한 도입 |
CA3161254A1 (en) | 2019-12-16 | 2021-06-24 | Katelijn D'HALLUIN | Improved genome editing using paired nickases |
CR20220485A (es) | 2020-02-28 | 2022-11-10 | Ionis Pharmaceuticals Inc | Compuestos y métodos para modular smn2 |
KR20220149567A (ko) | 2020-03-04 | 2022-11-08 | 바스프 에스이 | 이. 콜라이 및 바실루스에서의 발현을 위한 셔틀 벡터 |
EP4114954A1 (en) | 2020-03-04 | 2023-01-11 | Basf Se | Method for the production of constitutive bacterial promoters conferring low to medium expression |
TW202206596A (zh) | 2020-05-01 | 2022-02-16 | 美商Ionis製藥公司 | 調節atxn1之化合物及方法 |
US20230383321A1 (en) | 2020-05-15 | 2023-11-30 | Basf Se | Improved method for the production of isoprenoids |
BR112022024206A2 (pt) | 2020-06-29 | 2023-01-03 | Ionis Pharmaceuticals Inc | Compostos e métodos para modular plp1 |
US11730133B2 (en) | 2020-10-21 | 2023-08-22 | Equi-Nom Ltd | High yield sesame |
US11447521B2 (en) | 2020-11-18 | 2022-09-20 | Ionis Pharmaceuticals, Inc. | Compounds and methods for modulating angiotensinogen expression |
WO2022240931A1 (en) | 2021-05-11 | 2022-11-17 | Two Blades Foundation | Methods for preparing a library of plant disease resistance genes for functional testing for disease resistance |
CN117500815A (zh) | 2021-06-18 | 2024-02-02 | Ionis制药公司 | 用于降低ifnar1表达的化合物和方法 |
WO2023012342A1 (en) | 2021-08-06 | 2023-02-09 | Kws Vegetables B.V. | Durable downy mildew resistance in spinach |
WO2023031161A1 (en) | 2021-09-03 | 2023-03-09 | BASF Agricultural Solutions Seed US LLC | Plants having increased tolerance to herbicides |
US11395470B1 (en) | 2021-09-14 | 2022-07-26 | Equi-Nom Ltd. | Sesame with high oil content and/or high yield |
WO2023056269A1 (en) | 2021-09-30 | 2023-04-06 | Two Blades Foundation | Plant disease resistance genes against stem rust and methods of use |
WO2023067192A1 (en) | 2021-10-21 | 2023-04-27 | Consejo Superior De Investigaciones Cientificas (Csic) | Methods for improving abiotic stress resistance |
WO2023105244A1 (en) | 2021-12-10 | 2023-06-15 | Pig Improvement Company Uk Limited | Editing tmprss2/4 for disease resistance in livestock |
WO2023118136A1 (en) | 2021-12-22 | 2023-06-29 | BASF Agricultural Solutions Seed US LLC | Improved screening method for genome edited events |
WO2023131616A1 (en) | 2022-01-05 | 2023-07-13 | Vib Vzw | Means and methods to increase abiotic stress tolerance in plants |
WO2023131637A1 (en) | 2022-01-06 | 2023-07-13 | Vib Vzw | Improved silage grasses |
WO2023144199A1 (en) | 2022-01-26 | 2023-08-03 | Vib Vzw | Plants having reduced levels of bitter taste metabolites |
WO2024026474A1 (en) | 2022-07-29 | 2024-02-01 | Regeneron Pharmaceuticals, Inc. | Compositions and methods for transferrin receptor (tfr)-mediated delivery to the brain and muscle |
WO2024044352A1 (en) | 2022-08-26 | 2024-02-29 | The General Hospital Corporation | Methods and compositions for prognosis and treatment of dilated cardiomyopathy and heart failure |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4503151A (en) * | 1980-12-10 | 1985-03-05 | Research Corporation | Recombinant cDNA construction method and hybrid nucleotides useful in cloning |
US4873191A (en) * | 1981-06-12 | 1989-10-10 | Ohio University | Genetic transformation of zygotes |
US4882279A (en) * | 1985-10-25 | 1989-11-21 | Phillips Petroleum Company | Site selective genomic modification of yeast of the genus pichia |
DE3788914T2 (de) * | 1986-09-08 | 1994-08-25 | Ajinomoto Kk | Verbindungen zur Spaltung von RNS an eine spezifische Position, Oligomere, verwendet bei der Herstellung dieser Verbindungen und Ausgangsprodukte für die Synthese dieser Oligomere. |
US4950599A (en) * | 1987-01-29 | 1990-08-21 | Wolf Bertling | Method for exchanging homologous DNA sequences in a cell using polyoma encapsulated DNA fragments |
WO1990014092A1 (en) * | 1989-05-18 | 1990-11-29 | Cell Genesys, Inc. | Single-strand site-directed modification of mammalian genes in vivo |
DE69333082T2 (de) * | 1992-02-11 | 2004-05-06 | Cell Genesys, Inc., Foster City | Erzielen von homozygotem durch zielgerichtete genetische ereignisse |
DE69333955D1 (de) * | 1992-04-24 | 2006-02-02 | Stanford Res Inst Int | Targeting homologer sequenzen in eukaryotenzellen |
AU5087193A (en) * | 1992-08-21 | 1994-03-15 | Regents Of The University Of California, The | Composition and method for altering dna sequences by homologous recombination |
CA2159350A1 (en) * | 1993-03-31 | 1994-10-13 | Sudhir Agrawal | Modified oligonucleotides having improved anti-influenza activity |
-
1994
- 1994-12-09 DE DE69425903T patent/DE69425903T2/de not_active Expired - Fee Related
- 1994-12-09 NZ NZ278490A patent/NZ278490A/en unknown
- 1994-12-09 DE DE0733059T patent/DE733059T1/de active Pending
- 1994-12-09 AU AU13995/95A patent/AU691550B2/en not_active Ceased
- 1994-12-09 AT AT95905337T patent/ATE196311T1/de not_active IP Right Cessation
- 1994-12-09 EP EP95905337A patent/EP0733059B1/en not_active Expired - Lifetime
- 1994-12-09 WO PCT/US1994/014181 patent/WO1995015972A1/en active IP Right Grant
- 1994-12-09 CN CN94194935A patent/CN1048254C/zh not_active Expired - Fee Related
- 1994-12-09 CA CA002178729A patent/CA2178729A1/en not_active Abandoned
- 1994-12-09 ES ES95905337T patent/ES2149962T3/es not_active Expired - Lifetime
- 1994-12-09 PT PT95905337T patent/PT733059E/pt unknown
- 1994-12-09 DK DK95905337T patent/DK0733059T3/da active
- 1994-12-09 KR KR1019960703040A patent/KR100386337B1/ko not_active IP Right Cessation
- 1994-12-09 US US08/353,657 patent/US5565350A/en not_active Expired - Lifetime
- 1994-12-09 JP JP51636795A patent/JP3585238B2/ja not_active Expired - Fee Related
-
1996
- 1996-09-09 US US08/709,982 patent/US5756325A/en not_active Expired - Fee Related
-
1997
- 1997-12-02 US US08/982,866 patent/US5871984A/en not_active Expired - Fee Related
-
1998
- 1998-08-22 CN CN98118786A patent/CN1117866C/zh not_active Expired - Fee Related
-
2000
- 2000-12-04 GR GR20000402677T patent/GR3034988T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1117866C (zh) | 2003-08-13 |
CN1215755A (zh) | 1999-05-05 |
KR960706500A (ko) | 1996-12-09 |
AU1399595A (en) | 1995-06-27 |
KR100386337B1 (ko) | 2004-03-24 |
ES2149962T3 (es) | 2000-11-16 |
JP3585238B2 (ja) | 2004-11-04 |
NZ278490A (en) | 1998-03-25 |
DE733059T1 (de) | 1997-08-28 |
US5565350A (en) | 1996-10-15 |
US5756325A (en) | 1998-05-26 |
PT733059E (pt) | 2001-03-30 |
DK0733059T3 (da) | 2000-10-16 |
EP0733059B1 (en) | 2000-09-13 |
DE69425903D1 (de) | 2000-10-19 |
WO1995015972A1 (en) | 1995-06-15 |
US5871984A (en) | 1999-02-16 |
JPH09506511A (ja) | 1997-06-30 |
AU691550B2 (en) | 1998-05-21 |
CA2178729A1 (en) | 1995-06-15 |
EP0733059A1 (en) | 1996-09-25 |
GR3034988T3 (en) | 2001-03-30 |
DE69425903T2 (de) | 2001-02-15 |
EP0733059A4 (en) | 1997-05-21 |
ATE196311T1 (de) | 2000-09-15 |
CN1048254C (zh) | 2000-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1048254C (zh) | 用于将预定的改变引入靶基因中的化合物 | |
JP6888213B2 (ja) | 簡便で高効率の遺伝子改変非ヒト哺乳動物の作製方法 | |
US6573046B1 (en) | Eukaryotic use of improved chimeric mutational vectors | |
CN103388006B (zh) | 一种基因定点突变的构建方法 | |
AU2020223370B2 (en) | Enzymes with RuvC domains | |
KR20200103769A (ko) | 연장된 단일 가이드 rna 및 그 용도 | |
CN108463211A (zh) | 用于治疗肌联蛋白类肌病和其它肌联蛋白病变的材料和方法 | |
CN109475109A (zh) | 用于使用多个引导rna来破坏免疫耐受性的方法 | |
WO2010085699A2 (en) | Mammalian piggybac transposon and methods of use | |
JP6958917B2 (ja) | 遺伝子ノックイン細胞の作製方法 | |
EP4146800A1 (en) | Enzymes with ruvc domains | |
CN111718933B (zh) | 一种rrbp1基因敲除热带爪蛙模型的制备方法与应用 | |
CN113817734A (zh) | 一种hectd4基因敲除斑马鱼癫痫模型及其构建方法和应用 | |
JP2023542976A (ja) | カーゴヌクレオチド配列を転位させるための系および方法 | |
CN110938629B (zh) | 特异性识别猪Wip1基因的成套sgRNA及其应用和产品 | |
CN113957070A (zh) | 一种chd2基因敲除斑马鱼癫痫模型及其构建方法和应用 | |
KR20220039564A (ko) | 신규의 개량된 염기 편집 또는 교정용 융합단백질 및 이의 용도 | |
CN113897361A (zh) | 一种eef1b2基因敲除斑马鱼癫痫模型及其构建方法和应用 | |
US20240110167A1 (en) | Enzymes with ruvc domains | |
CN117965621A (zh) | 一种制备亮斑扁角水虻增重品系的方法及其核酸构建物 | |
CN117286169A (zh) | 一种由Tn7-CRISPR-Cas介导的需钠弧菌基因整合系统 | |
CN113897360A (zh) | 一种eef1b2基因敲除斑马鱼癫痫模型及其应用 | |
JP2020031546A (ja) | ゲノム編集技術 | |
Hamer | Recombinant DNA—an introduction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |